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Group testing, where groups of individual specimens are composited to test for
the presence or absence of a disease (or some other binary characteristic), is a
procedure commonly used to reduce the costs of screening a large number of
individuals. Statistical research in group testing has traditionally focused on a
homogeneous population, where individuals are assumed to have the same
probability of having a disease. However, individuals often have different risks of
positivity, so recent research has examined regression models that allow for
heterogeneity among individuals within the population. This dissertation focuses
on two problems involving group testing regression models.
For the first problem, we examine group testing regression models when
identification of the positive and negative statuses for individuals is performed.
The identification aspect leads to additional tests, known as “retests,” beyond
those performed for initial groups of individuals. We show how regression models
can be fit in this setting while also incorporating the extra information from these
retests. Through Monte Carlo simulations, we present evidence that significant
gains in efficiency occur by incorporating retesting information. Furthermore, we
demonstrate that some group testing protocols can actually lead to more efficient
estimates than individual testing when diagnostic tests are imperfect. Finally, we

show that halving and matrix testing protocols are the most efficient to use in
application.
For the second problem, we consider situations when individuals are tested in
groups for multiple diseases simultaneously. This problem is important because
assays frequently screen for more than one disease at a time. When these assays
are used in a group testing setting, the individual positive/negative statuses
consist of unobserved, correlated random variables. To estimate models in this
setting, we develop an expectation-solution based algorithm that provides
consistent parameter estimates and natural large-sample inference procedures.
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Chapter 1: Introduction
1.1 Background
When performing individual testing for an infectious disease, a specimen (e.g.,
blood, urine) is obtained from each subject and tested to determine the positive
or negative disease status of the subject. When there are a large number of
specimens and/or testing costs are high, this can result in excessive time and
expenditures to complete the screening process. In these situations, group testing,
where individual specimens are composited into pools for testing, has become
standard practice. If a pool tests negative, all individuals within it are diagnosed
as being negative. If a pool tests positive, there is at least one positive individual
within it; further retesting of those individuals can be completed to determine
individual diagnoses. As long as the overall prevalence of the disease is low and
appropriate group sizes are chosen, group testing can considerably reduce the
number of tests and associated costs when compared to individual testing.
The use of group testing in screening people for low-prevalence diseases has a
long history dating back to detecting syphilis among World War II soldiers
(Dorfman 1943). Subsequently, group testing has been successfully adopted in
many infectious disease applications, including blood donation screening by the
American Red Cross (American Red Cross 2012), opportunistic chlamydia and
gonorrhea testing in medical clinics (Gaydos 2005), and Bovine Viral Diarrhea
virus detection for the cattle industry (Munoz-Zanzi et al. 2006). Group testing
has also proven to be beneficial in areas outside of infectious disease prevalence
estimation and detection, including drug discovery experiments (Remlinger et al.
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2006), plant pathology (Tebbs and Bilder 2004), genotyping (Chi et al. 2009),
and food contamination testing (Fahey, Ourisson, and Degnan 2006).

1.2 Group Testing Regression Models
Group testing is generally used for two purposes: case identification and
prevalence estimation. In the context of infectious diseases, the goal of case
identification is to identify all individuals having a disease. In contrast, the goal
of prevalence estimation is to estimate the prevalence of a disease in a population.
The focus of this dissertation is prevalence estimation, and most research in this
area has examined estimating an overall prevalence in a homogeneous population
(e.g., Swallow 1985; Biggerstaff 2008; Hepworth and Watson 2009). However,
populations are frequently heterogeneous, where covariates, such as gender,
behavior, education level, …, may influence individual disease status. For this
reason, it is important to estimate covariate-specific probabilities of positivity. In
the remainder of this section, we review the two seminal works in this area – one
by Vansteelandt et al. (2000) and one by Xie (2001) – that have been proposed
to estimate these probabilities through group testing regression models.
Define Yik  1 if the ith individual in the kth group is positive and Yik  0
otherwise, for i = 1, …, Ik, k = 1, …, K. We assume that each individual is
assigned to exactly one group and that Yik are independent Bernoulli random
variables. Denote the observed group response for the kth group as Zk. If group
tests are perfectly accurate, a group tests positive (Zk = 1) if and only if



Y  0 and a group tests negative (Zk = 0) if and only if
i 1 ik
Ik



Ik

Yik  0 . The

i 1

group responses Zk are also independent Bernoulli random variables with mean k
≡ P(Zk = 1).
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Because assays are usually subject to testing errors, the sensitivity and
specificity of a test are defined as   P (Zk  1 | Zk  1) and   P (Zk  0 | Zk  0),
respectively, where Zk denotes the true response of group k. Vansteelandt et al.
(2000) and Xie (2001) both assumed that the sensitivity and specificity are
known and do not depend on pool size; these assumptions are reasonable with
properly calibrated modern diagnostic assays. Using the total probability
theorem, one can express k in terms of the true individual probabilities

pik  P (Yik  1) as
k  P (Zk  1 | Zk  1)P (Zk  1)  P (Zk  1 | Zk  0)P (Zk  0)
Ik

   (1    ) (1  pik ).

(1)

i 1

To incorporate risk factors that may influence an individual’s response, our goal

ik as a function of the covariates for each individual. The model
is to estimate p
of interest is

f (pik )  0  1x1ik  ...  p1x p1,ik ,

(2)

where f(×) is a known, monotonic, differentiable link function and x1ik, …, xp-1,ik are
the p – 1 covariates for the ith individual in the kth group.
As mentioned earlier, Vansteelandt et al. (2000) and Xie (2001) present two
different ways to find the maximum likelihood estimates for  = (0, 1, …, p-1).
Using Equation (1), Vansteelandt et al. (2000) writes the likelihood function in
terms of observed group responses zk:
K

L1   kzk (1  k )1zk
k 1

z

Ik

k
    (1    ) (1  pik )
k 1 
i 1

K

Ik


1    (1    ) (1  pik )

i 1


1zk
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for the model in (2). Maximizing L1 directly results in the parameter estimates
ˆ. The covariance matrix for ̂ can be obtained from the inverse of the observed


Fisher information matrix.
Alternatively, Xie (2001) expresses the likelihood function in terms of the
unobserved

individual

ikyik (1  p
ik )1yik ,
responses yik : L2  kK1 iIk 1 p

and

proposed the use of an EM algorithm in maximizing the likelihood function. The
algorithm works by replacing the unobserved outcomes yik in log(L2) by

ik  E (Yik |  ) where  denotes all information obtained by group tests and
retests under a particular group testing protocol. The expectation and
maximization steps of the EM algorithm are alternated between in an iterative
manner until convergence is reached. Formally, the following EM algorithm can
be used to obtain to obtain the maximum likelihood estimate of , denoted by ̂ :
1) Select a starting point (0) of .
2) E-step: For a given (b ) , b = 0, 1, 2, …, calculate ik(b )  E (Yik |  , (b ) ) , for i
= 1, …, Ik and k = 1, …, K.
3) M-step: Maximize the following function
K

Ik

E  log(L2 ) | z1,..., zK , (b )     ik(b ) log(pik )  (1  ik(b ) )log(1  pik )
k 1 i 1

for  to update the parameter estimates at the (b + 1)th
iteration.
4) Repeat Steps 2 and 3 until (b 1)  (b ) is very small; denote the final
solution by ̂ .
To estimate the covariance matrix of ̂ , Louis’s (1982) method can be applied to
obtain the Hessian matrix:
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N 
2   pj 
2
 
 


H n   j
p
log
[log(1
)]

j

j 1 
   1  pj   




    p  
     pj   

j





,
log 
log 
  (jj   j j  )
   1  pj     1  pj   
j 1 j 1




N

N

where we have re-indexed the subjects to be j = 1, …, N, N   kK1 I k ,

j j  |  ). The inverse of Hˆn , which is Hn
j  E (Yj |  ), and jj   E (YY
evaluated at ̂ , is used as the covariance matrix estimate.
Xie (2001) remarks that closed form expressions for ωik are not possible for
some group testing protocols (algorithm used for the initial testing and
subsequent retesting). In these cases, a Gibbs sampling approach can be
employed to estimate them; we will illustrate such technique in Section 2.2.4.
Because  can include information from any group or individual tests, Xie’s
(2001) method is very flexible and can deal with a wide range of complex group
testing protocols.
Several very recent papers have expanded on the work of these two seminal
papers in this area. Specifically, Bilder and Tebbs (2009) provide a thorough
comparison of individual and group testing regression model estimates. Chen et al.
(2009) examine mixed-effects models, and Delaigle and Meister (2011) and
Delaigle and Hall (2012) discuss a nonparametric modeling approach.

1.3 Group Testing Protocols Used for Identification
In this sub-section, we introduce group testing protocols that are commonly used
for case identification. In each of the protocols described next, there may be
multiple responses involving each individual due to retests, which makes a direct
evaluation of a likelihood function difficult. In later chapters, we will investigate
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how to incorporate the additional retest information from these protocols into
estimating the model given in (2).
1.3.1 Dorfman
Although group testing had been used earlier (see Hughes-Oliver (2006) for a
review), Dorfman (1943) is largely regarded as the seminal paper in the area.
Dorfman proposed screening pooled blood samples of US Army soldiers for
syphillis, followed by retesting all soldiers individually within positive pools.
Individuals within negative testing groups were declared negative. Due to its
simplicity, Dorfman’s protocol is the most widely adopted protocol for case
identification, and its applications include screening blood donations (Stramer et
al. 2004), chlamydia screening (Mund et al. 2008), and potato virus detection
(Liu et al. 2011).
1.3.2 Halving
The halving protocol is an alternative to Dorfman’s protocol, where positive
testing groups are successively split into two equal sized subgroups. If a subgroup
tests negative, no further splitting is needed and its members are declared
negative; if a subgroup tests positive, it is further split and tested until all
subgroups test negative or until individual testing occurs. For example, the first
step of a 3-stage halving protocol with a group of size I = 8 is to test the whole
group. If the group tests positive, it is split into two subgroups of size 4. If either
subgroup tests positive, all individuals within a positive subgroup are tested. If a
4-stage halving protocol is used instead, we would have one more round of
splitting the subgroups before individual testing. For simplicity, we only consider
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the 3-stage halving protocol in this dissertation. The early use of halving protocol
dates back to Sobel and Groll (1959). More recently, Litvak et al. (1994)
proposed the use of halving protocol and its variations in detection of HIV
infections in blood donations.
1.3.3 Array testing
The array testing protocol, first proposed by Phatarfod and Sudbury (1994),
assigns individuals to overlapping groups arranged into a two-dimensional array
structure. Specimens are pooled within each row and within each column for
testing. Intersections of positive testing rows and columns indicate where positive
individuals may exist. When more than one row and more than one column test
positive, ambiguities arise on which of these individuals at the intersections led to
the positive row and column test results. We may also have one or more rows
testing positive and no columns testing positive (or vice versa) when testing
errors are present. To clear these ambiguities, additional testing (usually on each
individual) can be used to complete the decoding. The array testing protocol has
found much success in high throughput screening applications, such as infectious
disease testing (Tilghman et al. 2011), DNA screening (Berger et al. 2000), and
systems biology (Thierry-Mieg 2006).

1.4 Motivation and Objectives
The Centers for Disease Control and Prevention and the Office of Population
affairs support the Infertility Prevention Program (IPP) in order to reduce the
prevalence of chlamydia and gonorrhea in the United States, while also to better
understand factors affecting prevalence (Centers for Disease Control and
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Prevention, 2012). Each state participates in the IPP. In Nebraska, health care

clinics across the state obtain urine and swab specimens to test for the diseases.
These specimens are sent to the Nebraska Public Health Laboratory (NPHL) for
testing where in total approximately 25,000 tests are performed yearly for these
diseases. Along with the specimens, each individual screened contributes a set of
information, such as age, gender, symptoms, and past history of risky behavior.
Clinical observations are made as well on each individual, including cervical
friability, pelvic inflammatory disease, cervicitis, and urethritis statuses.
All current testing at the NPHL is performed individually on each specimen;
i.e., group testing is not used. Due to the large number of specimens screened
annually and the high cost associated with these tests (approximately $11 for a
swab test and $16 for a urine test), group testing could be very efficient and
beneficial if employed by the NPHL. In particular, in order to understand how

certain risk factors influence the disease statuses, one can fit a group testing
regression model that estimates an individual’s probability of having chlamydia or

gonorrhea at a largely reduced cost, as compared to testing specimens
individually. In later chapters, we will detail how group testing could be used by
the NPHL and the benefits associated with its use.
In many applications, prevalence estimation and case identification are
simultaneous goals. For example, the goals of the IPP involve not only the
identification of positive individuals, but also to evaluate risk factors closely
related to infection. Even in public health studies where prevalence estimation is
the primary goal and only the initial group tests are needed, retests on
individuals are frequently performed for ethical reasons. Although Xie (2001)
proposed the general EM algorithm framework for group testing regression
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problems, details on how to implement his proposal for specific group testing
protocols were not given for any of the commonly used protocols described in
Section 1.3. Furthermore, it is unknown which protocol results in the more
efficient estimators. In Chapter 2, we examine how the general EM algorithm of
Xie (2001) can be applied to these three group testing protocols introduced in
Section 1.3 and develop recommendations on their use.
In practice, there are many cases where testing is done not only for one
disease, but for multiple diseases at the same time. For example, one assay is
used at the NPHL to test for chlamydia and gonorrhea simultaneously. Also, the
American Red Cross screens blood donations for HIV, hepatitis B, hepatitis C,
and West Nile Virus through using group testing (American Red Cross 2012;
Dodd et al. 2002; Stramer et al. 2004). With respect to group testing, HughesOliver and Rosenberger (2000) is the lone paper that addresses the multipledisease problem, and they only examined the homogeneous population situation.
The purpose of Chapter 3 then is to take advantage of covariate information to
model individual statuses of multiple diseases simultaneously in a group testing
setting. In general, we are proposing a regression model for unobserved correlated
binary responses.

1.5 Organization of the Dissertation
The remainder of this dissertation is organized as follows. Chapter 2 is a paper
under review by Biometrical Journal. The paper shows how regression models
can be fit to group testing data from three commonly used group testing
protocols: Dorfman, halving, and array testing, as described in Section 1.3.
Simulation evidence is presented to show significant efficiency gains from
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incorporating retests into the estimation process, as compared to using the initial
group test results alone. We also discover that group testing with retests can
result in more efficient estimators than individual testing when testing error is
present. Thus, not only will group testing lead to a smaller number of tests, but
more information can be gained by using group testing. Finally, we investigate
which group testing protocol leads to the most efficient estimators overall.
Chapter 3 contains almost all of a paper that is under review at Statistics in
Medicine (an additional example, set of simulations, and parts of the paper’s
discussion section were completed by my advisor, so they are omitted from the
dissertation). In this paper, we propose the first regression techniques for
multiple-disease group testing data. We develop an expectation-solution based
algorithm that takes into account the correlation structure of unobserved
individual disease statuses. Simulation studies show the consistency of our
estimators as well as efficiency gains in parameter estimates when compared to
single-disease group testing models.
Chapter 4 includes additional research completed that did not fit into
Chapters 2 and 3. We show how to generalize the model-fitting procedure of
Chapter 3 to incorporate individual retesting information. We also present
alternative approaches to the methods proposed in Chapters 2 and 3. To
conclude, we present a discussion of future directions for research involving group
testing regression models.
Both Chapters 2 and 3 contain the references as given in their corresponding
papers. We also include all references cited throughout the dissertation in a
separate references section toward the end of the dissertation. All appendices are
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located at the end of the dissertation. These include appendices that were “web
appendices” for the paper submissions.
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Chapter 2: Paper #1 - Group Testing
Regression Model Estimation when Case
Identification is a Goal
Abstract
Group testing is frequently used to reduce the costs of screening a large number
of individuals for infectious diseases or other binary characteristics in small
prevalence situations. In many applications, the goals include both identifying
individuals as positive or negative and estimating the probability of positivity.
The identification aspect leads to additional tests being performed, known as
“retests,” beyond those performed for initial groups of individuals. In this paper,
we investigate how regression models can be fit to estimate the probability of
positivity while also incorporating the extra information from these retests. We
present simulation evidence showing that significant gains in efficiency occur by
incorporating retesting information. Furthermore, we demonstrate that some
group testing protocols can actually lead to more efficient estimates than
individual testing when diagnostic tests are imperfect. Finally, we examine which
protocols are the most efficient to use in application. Our methods are illustrated
using chlamydia screening data from the Infertility Prevention Project.

Key words: Binary response; Generalized linear model; EM algorithm; Latent
response; Pooled testing; Prevalence estimation.
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2.1 Introduction
Pooling specimens to screen a population for infectious diseases has a long history
dating back to Dorfman’s (1943) proposal to screen American soldiers for syphilis
during World War II. Today, testing individuals in pools through group testing
(also known as “pooled testing”) has been successfully adopted in many
additional areas, including entomology (Gu et al. 2004), veterinary medicine
(Muñoz-Zanzi et al. 2000), DNA screening (Berger et al. 2000), and drug
discovery (Kainkaryam and Woolf 2009). When compared to testing specimens
individually, group testing can provide considerable savings in time and costs
when the overall prevalence of the disease (or some other binary characteristic of
interest) is low. This makes the use of group testing particularly desirable in
applications where there are limitations in resources.
Group testing is generally used for two purposes: case identification and
prevalence estimation. The goal of case identification is to identify all individuals
as being positive or negative. Individual specimens are initially pooled into
groups, and these groups are tested. Individuals within positive testing groups are
then retested in some prior specified way to distinguish positive individuals from
those that are negative. The goal of prevalence estimation is to estimate the
prevalence of positivity in a population. Retesting is not needed in this case
because initial group test responses alone can be used to estimate the prevalence.
However, when prevalence estimation and case identification are simultaneous
goals, the additional retesting information can be used for estimation as well.
Intuitively, one would expect statistical benefits (e.g., in terms of efficiency) from
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including retest outcomes as part of the estimation process. Our paper examines
how to include retests while also quantifying the benefits from their inclusion.
The majority of group testing estimation research has focused on inference for
an overall prevalence p using only the results from the initial group tests (e.g.,
Swallow 1985; Biggerstaff 2008; Hepworth and Watson 2009). A few papers, such
as Sobel and Elashoff (1975) and Chen and Swallow (1990), discuss including
retests to estimate p, but under the restriction of perfect testing and without
positive case identification. More recently, estimation research has focused on
regression modeling to obtain an estimate of individual positivity, given a set of
risk factors. The seminal papers in this area, Vansteelandt et al. (2000) and Xie
(2001), both propose likelihood-based estimation and inference using binary
regression models, but their approaches differ. Vansteelandt et al. (2000) use a
likelihood function written in terms of the initial group responses, and standard
techniques for generalized linear models are used to find the parameter estimates
that maximize this function. Xie (2001) uses a likelihood function written in
terms of the true latent individual statuses and then employs the EM algorithm
to maximize the likelihood function. The main advantage of Xie’s approach is
that it allows for the inclusion of retests.
Given the large number of ways to retest individuals within positive groups
(see Hughes-Oliver (2006) for a review), it is important to determine if there are
benefits from including retest outcomes when estimating a group testing
regression model. The purpose of our paper is to determine if benefits truly exist,
and, in particular, determine which group testing protocol (algorithm used for the
initial testing and subsequent retesting) is the most efficient. This is especially
important because group testing is typically applied in settings where cost and
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time considerations are a primary concern. Ideally, one would want to apply a
protocol that results in the fewest number of tests while also producing the most
efficient regression estimates. Also, model estimation plays a significant role in
the application of informative retesting procedures for case identification (e.g., see
Bilder et al. (2010) and Black et al. (2012)). These identification procedures rely
on group testing regression models to identify which individuals are most likely
to be positive, so having the best possible estimates is crucial.
The order of our paper is as follows. Section 2.2 reviews three commonly used
group testing protocols. Note that each of these protocols are not specifically
examined in Xie (2001), so this is the first time that the EM algorithm details
have been formally presented for them. In Section 2.3, we use simulation to
investigate the benefits from including retests and determine which protocol is
the most efficient. This section also shows that group testing can actually be
more efficient than individual testing when estimating regression parameters. In
Section 2.4, we apply these protocols to chlamydia screening data from the
Infertility

Prevention

Project,

where

both

identification

and

prevalence

estimation are important. Finally, Section 2.5 summarizes our findings and
discusses extensions to this research.

2.2 Estimation of Group Testing Regression Models
Define Yik  1 if the ith individual in the kth initial group is truly positive and

Yik  0 otherwise, for i = 1, …, Ik and k = 1, …, K. Our goal is to estimate
E (Yik )  pik , conditional on a set of covariates x1ik, …, xp1,ik, using the regression
model

f (pik )  0  1x1ik  ...  p1x p1,ik ,

(3)
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where f(×) is a known monotonic, differentiable function. The log-likelihood
function can be written as
K

Ik

log[L()]    yik log(pik )  (1  yik )log(1  pik ),

(4)

k 1 i 1

where   (0 , , p1 ) and we assume that the Yik

are independent

Bernoulli(pik ) random variables. If the true individual statuses Yik were
observed, likelihood-based estimation for the model would proceed in a
straightforward manner.
In group testing applications, the individual statuses Yik are unknown because
only group responses may be observed and because groups and/or individuals
may be misclassified due to diagnostic testing error. To fit the model, Xie (2001)
proposed the use of an EM algorithm to find the parameter estimates that
maximize the likelihood function. The algorithm works by replacing the
unobserved outcomes yik in Equation (4) by ik  E (Yik |  ) , where  denotes all
information obtained by group tests and retests under a particular group testing
protocol. The expectation and maximization steps of the EM algorithm are
alternated between in an iterative manner until convergence is reached to obtain
the maximum likelihood estimate of , denoted by ̂ . The estimated covariance
matrix of ̂ is obtained by standard methods; e.g., see Louis (1982) and Xie
(2001, p. 1960).
The most difficult aspect of the EM algorithm application is to obtain the
conditional expectations ik. Xie (2001) provides derivation details only for the
protocol outlined in Gastwirth and Hammick (1989), which involves testing
individuals in non-overlapping groups and performing one confirmatory test on
groups that test positive. While this protocol can be extremely useful for
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estimation purposes, it can not be used to identify positive individuals. In this
paper, we consider three group testing protocols commonly used in practice for
case identification. The following subsections elaborate on how to calculate the
conditional expectations ik for each protocol. Given these details, the EM
algorithm for fitting Equation (3) becomes straightforward to implement.
2.2.1 Initial Group Tests from Non-Overlapping Groups
Initial tests from groups that are non-overlapping (i.e., each individual is within
only one group) do provide enough information to estimate Equation (2),
although not as efficiently as other case identification protocols to be discussed
shortly. We begin by describing how models can be fit under this setting to
motivate model fitting when retests are included.
Define Zk as the response for initial group k, where Zk = 1 denotes a positive
test result and Zk = 0 denotes a negative test result. Because diagnostic tests are
likely subject to error, we define the true status of a group by Zk where a 1 (0)
again denotes a positive (negative) status. The sensitivity and specificity of the
group test are given by   P (Zk  1 | Zk  1) and   P (Zk  0 | Zk  0), where we
assume these values are known and do not depend on group size. These
assumptions are consistent with most research for group testing regression,
including Vansteelandt et al. (2000) and Xie (2001). When only the initial group
responses are observed, ik is easily found as

P (Yik  1 | Zk  0)  (1  )pik / (1  k ), if Zk  0
ik  
 
P (Yik  1 | Zk  1)   pik / k ,
if Zk  1,



where

(5)
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k  P (Zk  1 | Zk  1)P (Zk  1)  P (Zk  1 | Zk  0)P (Zk  0)
Ik

     (1  pik )
i 1

is the probability that group k tests positive and  = 1 −  − .
2.2.2 Dorfman
After initially testing individuals in non-overlapping groups, Dorfman (1943)
proposed to individually retest all specimens within the positive testing groups.
Individuals within negative testing groups are declared negative. Because of its
simplicity, Dorfman’s protocol is the most widely adopted protocol for case
identification, and its applications include screening blood donations (Stramer et
al. 2004), chlamydia testing (Mund et al. 2008), and potato virus detection (Liu
et al. 2011).
Because specimens are retested, ik is no longer the same as given in Equation
(5) when a group tests positive. Let Yik denote the retest outcome for individual i
in group k and assume that the same assay for group tests is also used for
individual retests (thus,  is the sensitivity and  is the specificity for properly
calibrated tests). For observed positive groups (Zk  1), we have calculated
ik  P (Yik  1 | Y1k  y1k ,...,YIk k  yIk k , Zk  1)
1



pik P (Yik  yik | Yik  1)   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
i i yi k 0



  P (Yi k  yi k | Yi k  0)(1  pi k ) 
 i 1


Ik

Ik
1


   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )

i 1 yi k 0



Derivation details are provided in Appendix A.

.
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2.2.3 Halving
As its name suggests, halving works by first splitting a positive testing initial
group into two equally (or as close to as possible) sized subgroups for retesting.
Whenever a subgroup tests negative, all of its individuals are declared negative
and no further splitting is performed. Whenever a subgroup tests positive,
continued splitting occurs in the same manner until only individuals remain.
Early origins of the halving protocol go back as far as Sobel and Groll (1959).
More recently, halving and its close variants have been used in a number of
infectious disease screening applications, including Litvak et al. (1994) and
Priddy et al. (2007). Halving has even been described in the product literature for
high throughput screening platforms (Tecan Group Ltd. 2007).
For a group of size Ik = 2s, there are s possible hierarchical splits that contain
a particular individual specimen, where the last split results in individual testing.
For practicality reasons, all possible hierarchical splits are rarely implemented.
Instead, individual testing is performed on subgroups at a pre-determined tth
split, where t  s. For this reason, we will only consider the t = 2 case, so that
an individual can be tested at most three times.
To find ik under halving, we continue to define Zk as the initial group
response for group k, k = 1, …, K. If the initial group tests positive (Zk = 1), it is
split into two subgroups that we denote by k1 and k2. The two subgroups are
subsequently tested and provide the corresponding binary responses Zk1 and Zk2. If
either subgroup tests positive, the third and final step is to individually test all
members within a subgroup, where we continue to define Yik as the individual
retest outcome for individual i from initial group k. To denote the true statuses
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for the groups, subgroups, and individual tests under halving, we again use a
tilde over the respective letter symbol. We also continue to assume a constant
sensitivity and specificity for each test regardless of the group size.
For the halving protocol outlined above, there are five possible testing
scenarios involving the initial group and its two subgroups. These scenarios are:
1) Zk = 0: Group k tests negative,
2) Zk = 1, Zk1 = 0, Zk2 = 0: Group k tests positive, but both subgroups test
negative,
3) Zk = 1, Zk1 = 1, Zk2 = 0: Group k tests positive, subgroup k1 tests positive
leading to individual testing for its members, and subgroup k2 tests
negative,
4) Zk = 1, Zk1 = 0, Zk2 = 1: Group k tests positive, subgroup k1 tests negative,
and subgroup k2 tests positive leading to individual testing for its
members,
5) Zk = 1, Zk1 = 1, Zk2 = 1: Group k tests positive and both subgroups test
positive leading to individual testing for members of both subgroups.
In Table 2.1, we provide expressions for ik in each of these scenarios. Derivations
are similar to those given in Section 2.2.2, but they are much more tedious due to
the additional split in the testing process. We present the derivations in
Appendix B.
2.2.4 Array Testing
Both Sections 2.2.2 and 2.2.3 describe protocols where individuals are initially
tested in non-overlapping groups. Phatarfod and Sudbury (1994) proposed a
fundamentally different protocol where specimens are arranged into a two-
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dimensional array. Samples from specimens are combined within rows and within
columns so that each individual is tested twice in overlapping groups. Specimens
lying outside of any positive rows and columns are classified as negative.
Specimens lying inside a positive row and/or column are potentially positive.
This protocol is known as array (matrix) testing, and it is widely applied in high
throughput screening applications, such as infectious disease testing (Tilghman et
al. 2011), DNA screening (Berger et al. 2000), and systems biology (Thierry-Mieg
2006).
Because individuals are initially tested within one row and one column, we
must modify our notation to reflect this. Define Yij as the true binary status (0
denotes negative, 1 denotes positive) for the individual whose specimen is located
within row i and column j, for i = 1, …, I and j = 1, …, J. With this slight
change in notation, our group testing regression model now can be rewritten as

f (pij )  0  1x1ij  ...  p1x p1,ij ,
where the Yij are independent Bernoulli(pij ) random variables, and the full-data
log-likelihood function can be rewritten as
I

J

log[L()]    yij log(pij )  (1  yij )log(1  pij ),
i 1 j 1

if the true individual statuses were observed. In most screening applications,
there will be more than IJ individuals, so more than one array will be needed. In
those cases, we could add a third subscript to Yij to denote the array and include
a third sum over the arrays in log[L()]. We avoid doing this for brevity.
As before, because the individual statuses are not observed directly, the EM
algorithm is used to fit the regression model. Define R = (R1, …, RI) and C =
(C1, …, CJ) as vectors of row and column binary responses, respectively, for one
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array. If identification of positive individuals is of interest, specimens lying at the
intersections of positive rows and columns are retested individually. Additionally,
specimens in positive testing rows without any positive testing columns in the
array, which can occur when there is testing error, should be retested as well.
The same is true when columns test positive without any rows testing positive.
Without loss of generality, we denote the collection of all potentially positive
individual responses by YQ  (Yij )(i, j )Q where Q is the index set pertaining to the
individual tests, that is

Q  {(s, t ) | Rs  1, Ct  1, 1  s  I , 1  t  J
or Rs  1, C1    CJ  0, 1  s  I
or R1    RI  0, Ct  1, 1  t  J }.
If there are no individual tests performed at all, we simply let Q = Æ, the empty
set.
Using all available test responses, we need to obtain the conditional expected
value ij  E (Yij |  ) ; however, when array testing is used as described above,
there is no longer a closed form expression for it. Therefore, as suggested by Xie
(2001), we implement a Gibbs sampling approach to estimate ij. This involves
successive sampling from the univariate conditional distribution of Yij given R =
r, C = c, YQ = yQ, and all of the other true individual binary statuses in the
array, and this sampling is performed for each i and j. After a large set of
samples, all of the simulated yij values for each i and j can be averaged to find
an estimate of ij. Implementation details are described next.
For

a

given

row

and

column

combination

(i,

j),

define Yi, j 

{Yi , j  : i   1,..., I , j   1,..., J ,(i , j )  (i, j )} ; i.e., all possible true individual
i , j , r , c, yQ is
statuses excluding Yij . The conditional distribution for Yij | y
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Bernoulli(ij )

,

where

ij  P (Yij  1 | Yi, j  yi, j , R  r ,C  c,YQ = yQ ) which we derive in
Appendix C. With these conditional distributions, we generate samples
(b )
(b )
for b = 1, …, B, using the most updated yi, j . The estimate for ij
y11
, , yIJ

is then taken to be ˆij  (B  a )1 bBa 1 yij(b ), where a is a sufficiently large

ˆij
number of burn-in samples. The EM algorithm proceeds as usual where 
replaces ij in each E-step. The negative information matrix can be estimated
using these B Gibbs samples (e.g., see Xie (2001, p. 1961)).

2.3 Simulation Study
We use simulation to evaluate the regression estimates resulting from the group
testing protocols described in Section 2.2. To begin, we consider the model

logit(pik )  0  1xik , which is equivalently logit(pij )  0  1xij for the array
testing protocols. We let 0 = -7 and 1 = 0.1 and simulate covariates from a
gamma(17,

1.4)

distribution.

The

regression

parameters

and

covariate

distribution are chosen to produce a realistic group testing setting where most
individuals have low risks of being positive and a few individuals having higher
risks. Appendix D provides a histogram of the true individual probabilities for
one simulated data set under these settings. Note that the overall mean
prevalence is approximately 0.01.
ij
Based on the logit model, we obtain the true probability of positivity pik ( p

for array testing), which in turn is used to simulate a true individual status Yik
(Yij for array testing). Individuals are then randomly assigned to groups of size I

(II arrays are used for array testing). Group, subgroup, and individual test
responses for each protocol are simulated next by using  and  as Bernoulli
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success probabilities. Group testing regression models are fit to these resulting
responses. For comparison purposes, we also fit a model to individual testing data
when testing error is present using the methodology outlined in Neuhaus (1999).
We repeat the same simulation process for each simulated data set of size 5000
individuals. Large sample sizes such as this are common in group testing
applications, including the example in Section 2.4.
2.3.1 Estimator Accuracy and Variance Estimation
Table 2.2 presents results on the accuracy of the parameter estimators and their
standard errors for group sizes I = 4, 12, 20 and  =  = 0.99. The mean rows
give each regression parameter estimate averaged over 1000 simulated data sets.
The SE/SD rows examine the accuracy of the standard error estimates, where SD
denotes the sample standard deviation of estimates across all simulated data sets,
and SE denotes the corresponding averaged standard errors. Thus, a SE/SD ratio
close to 1 suggests that the true standard errors are being estimated correctly.
Note that because Gibbs sampling is used for array testing, the EM algorithm is
much slower, so our array testing results are based on 300 simulated data sets.
We see from Table 2.2 that using the non-overlapping initial groups (IG;
Section 2.2.1) results in comparatively poor estimates of the parameters and their
standard errors. These estimates and standard errors become increasingly worse
as the group size grows. In contrast, all of the other protocols perform similarly
to individual testing, where averaged parameter estimates are close to
corresponding true values and SE/SD ratios are close to 1. As these results show,
there are important benefits from including retesting information from the
Dorfman and halving protocols.
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2.3.2 Improvements in Variance Estimation from Including Retests
As the results in Section 2.3.1 demonstrate, parameters and their corresponding
standard errors can be estimated well when retests are included. In this
subsection, we investigate directly the benefits of including retest information and
how this extra information affects the slope estimator precision. Define the
relative efficiency for ̂1 as

1 B Var (ˆ1,b,No retest )
RE(ˆ1,Retest to ˆ1,No retest )  
,
B b 1 Var (ˆ1,b,Retest )

(6)

where B denotes the number of simulations, ˆ1,b,Retest denotes the estimator for 1
when retests are included in the bth simulated data set, and ˆ1,b,No retest is defined
similarly when retests are not included. Note that we use the true variances in
Equation (6), rather than estimated variances, due to the length of time it takes
to fit a model for array testing. For Dorfman and halving, we compare their
variances to IG. For array testing, we compare variances with and without
retests.
Figure 2.1 displays the relative efficiencies from B = 500 new simulated data
sets for group sizes I = 4, 6, …, 20 when  =  = 0.99 and  =  = 0.95. Overall,
we see very large efficiency gains from including retesting information. Using
retests with array testing provides the smallest gain (but still noteworthy), which
is likely due to each individual already being part of two groups even if no retests
are performed. Halving results in larger gains than Dorfman, where the
differences between them are more pronounced for smaller  and . This occurs
because halving generally will always result in a lower classification error rate
than Dorfman (e.g., see Black et al. 2012), which then leads to less uncertainty in
the parameter estimates under halving. Overall, the efficiencies for all protocols
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grow as the group size does. This is explained by the fact that protocols without
retests observe less information as the group size increases. In contrast, retesting
will moderate the amount of information lost for larger group sizes.
Figure 2.2 provides plots of the averaged Var (ˆ1 ) for all simulated data sets.
One will note that the averaged Var (ˆ1 ) for the two testing protocols without
retests increases as the group size increases. This is similar to Figure 2.2 where it
was shown that RE(ˆ1,Retest to ˆ1,No retest ) increases as a function of the group size.
Conversely, when retests are included in a protocol, the averaged Var (ˆ1 )
changes very little across the group sizes because positive individuals are still
identified (subject to testing error).
Ordered by their averaged Var (ˆ1 ) , we can informally write Dorfman >
halving > array testing with retests. Interestingly, each of these protocols (and
also array testing without retests for smaller sensitivity, specificity, and group
size levels) has a smaller variance than that found through individual testing,
while also resulting in a smaller number of tests (see Appendix E). In other
words, not only do these protocols have the potential to drastically reduce the
costs needed for classification, but these protocols provide better regression
estimates! Note that Liu et al. (2012, Theorem 2) has recently observed this same
phenomenon in the absence of covariates. Through additional simulations (not
shown), we have seen that the gains from group testing in estimation efficiency
(over individual testing) do diminish as the assay sensitivity and specificity both
approach 1. This is an expected result because both individual and group testing
are likely to find all positive and negative individuals when assays are perfect or
nearly perfect.
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2.3.3 Average Number of Tests per Unit of Information
Each protocol uses a different number of tests to estimate the regression
parameters. To take this aspect into account, we define the average number of
tests per unit of information for 1 to be


1 B
nb
1 B
  nbVar (ˆ1,b ),

B b 1 1 / Var (ˆ1,b ) B b 1

(7)

where nb is the total number of tests performed for a protocol and ˆ1,b is the
estimated 1 for the bth simulated data set. The smaller that  is, the fewer the
number of tests are needed comparatively to obtain the same amount of
information about 1. A similar measure was used by Chen and Swallow (1990, p.
1037) when evaluating the benefits of retesting for overall prevalence estimation.
Figure 2.3 plots values of  for all group testing protocols for the same
simulations as in Section 2.3.2. Individual testing results in  = 3.53 for  =  =
0.99 and  = 8.80 for  =  = 0.95; these values were excluded from the figure to
avoid distorting the plots. Comparing between the plots, we see that  is larger
for  =  = 0.95 than for  =  = 0.99, which is a byproduct of increased
uncertainty when  and  are smaller. Within each plot, we again see the benefits
of including retests in the estimation process. Dorfman, halving, and array testing
with retests have smaller  values than their corresponding protocols that do not
include retests. Among those that include retests, halving always provides a
smaller  than Dorfman’s protocol. Also, array testing with retests provides
values of  close to that of halving for larger group sizes.
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2.3.4 Additional Simulations
To determine if our findings in this section remain in other situations, we have
performed a number of additional simulations. These simulations include using a
different covariate distribution and different regression parameter values, which
also allows us to examine different overall prevalence levels. In summary, we have
found that the same conclusions hold in these other situations, and some of these
results are included in Appendix F.

2.4 Infertility Prevention Project
The purpose of the Infertility Prevention Project (IPP) in the United States is to
prevent complications from chlamydia and gonorrhea infections that lead to
infertility. Annually, over 3 million screenings for these infections are reported to
the IPP program. Due to the large number of tests, some states, including Idaho
and Iowa, already use group testing to reduce costs. For this dissertation, we will
examine data from Nebraska, where individual testing is performed at the
Nebraska Public Health Laboratory (NPHL) for the entire state. In order to
reduce costs, the laboratory has an interest in adopting group testing – not only
to reduce the number of tests, but also to estimate risk factor specific
probabilities of infection. Thus, both case identification and estimation are
important goals for the NPHL.
We focus on the 6,139 test results from males who had their urine tested for
chlamydia in 2009. To examine how group testing would have worked with these
individuals, we artificially construct group, subgroup, and individual retest
responses for each group testing protocol by treating the known individual test
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results as the true statuses. Each test response is simulated by taking into
account assay sensitivity and specificity at the NPHL ( = 0.93,  = 0.95). Initial
groups are formed chronologically based on when specimens arrived at the
NPHL. The “optimal” sizes for these initial groups are found by minimizing the
expected number of tests (e.g., see Kim et al. (2007) for expected value formulas)
as a function of the 2008 overall prevalence of 0.077. These optimal group sizes
are 5 for IG and Dorfman and 8 for halving and array testing.
A first-order logit regression model is fit to the responses from each protocol
with the following covariates: age, race (represented by three indicator variables),
symptoms, urethritis, and risk history variables (multiple partners, new partner
in the last 90 days, contact with someone who has a sexually transmitted
disease). All covariates are dichotomous (0 and 1) except for age. For comparison
purposes, we again fit the same model to the original individual responses while
incorporating testing errors using the methodology of Neuhaus (1999).
Table 2.3 gives the parameter estimates from all fitted models and the number
of tests required for each protocol. Overall, all estimates are close to each other
for the same corresponding covariates. Each group testing protocol that includes
retests has smaller standard errors than those for the individual testing model,
consistent with our findings in Section 2.3. Using a level of significance of 0.05
with Wald tests, individual testing and group testing protocols with retests agree
on the same set of important covariates. These results illustrate the potential
advantages of using group testing at the NPHL–both in terms of estimation and
the resulting large-sample inference, but also because of the opportunity to
drastically reduce the number of tests needed. For example, halving requires 2898
tests overall, which is a 52.7% reduction from individual testing. Even the
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simpler Dorfman protocol requires only 3458 tests overall, a 43.7% reduction in
tests when compared to individual testing.

2.5 Discussion
In this chapter, we have outlined how to estimate a group testing regression
model when retesting information is available from three commonly used
protocols. Functions to fit the models are available in R’s binGroup package
(Bilder et al. 2010). Including retests leads to large reductions in estimator
variability while also improving estimator accuracy. Overall, halving and array
testing with retests are the best protocols when taking into account the number
of tests as well as the estimator variability. We also showed that group testing
can lead to more efficient estimates of regression parameters than individual
testing. This is an extremely important finding, because it shows that more
information can be gained from a statistical analysis by actually doing less in
terms of testing.
Group size selection is an important consideration in most applications where
group testing is used (e.g., see Swallow (1985)). Aside from assay considerations,
the optimal group size is the one that leads to the smallest number of tests while
still providing as much information as possible. Our research shows the average
number of tests per unit of information stays relatively stable over a large range
of group sizes when retests are included. Thus, protocols with retests are
somewhat robust to the group size used, which makes its choice not as critical as
when retesting is omitted.
The EM algorithm proposed by Xie (2001) can be used to fit models for data
arising from any group testing protocol. While our paper focused on three
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commonly used protocols for case identification, other protocols exist. In
particular, array testing can be implemented with a master group for each array
and/or in more than two dimensions (Kim et al. 2007; Kim and Hudgens 2009).
Future research could examine these other protocols to determine if more
estimation benefits result from their implementation. In the case of array testing,
all protocols will likely need to use the Gibbs sampling approach outlined in
Section 2.2.4 to estimate a conditional expectation for every cell within an array.
This can be time consuming depending on the size of the arrays and how many
arrays there are. Potentially, parallel processing could be used with one core
processor per array to reduce the model fitting time.

2.6 References
Berger, T., Mandell, J., and Subrahmanya, P. (2000). Maximally efficient twostage screening. Biometrics 56, 833-840.
Biggerstaff, B. (2008). Confidence intervals for the difference of two proportions
estimated from pooled samples. Journal of Agricultural, Biological, and
Environmental Statistics 13, 478-496.
Bilder, C., Tebbs, J., and Chen, P. (2010). Informative retesting. Journal of the
American Statistical Association 105, 942–955.
Bilder, C., Zhang, B., Schaarschmidt, F., and Tebbs, J. (2010). binGroup: A
package for group testing. R Journal 2, 56-60.
Black, M., Bilder, C., and Tebbs, J. (2012). Group testing in heterogeneous
populations using halving algorithms. Journal of the Royal Statistical Society,
Series C 61, 277-290.
Chen, C. and Swallow, W. (1990). Using group testing to estimate a proportion,
and to test the binomial model. Biometrics 46, 1035–1046.
Dorfman, R. (1943). The detection of defective members of large populations.
Annals of Mathematical Statistics 14, 436-440.

32
Gastwirth, J. and Hammick, P. (1989). Estimation of prevalence of a rare
disease, preserving anonymity of subjects by group testing: application to
estimating the prevalence of AIDS antibodies in blood donors. Journal of
Statistical Planning and Inference 22, 15–27.
Gu, W. Lampman, R., and Novak, R. (2004). Assessment of arbovirus vector
infection rates using variable size pooling. Medical and Veterinary
Entomology 18, 200–204.
Hepworth, G. and Watson, R. (2009). Debiased estimation of proportions in
group testing. Journal of the Royal Statistical Society, Series C 58, 105-121.
Hughes-Oliver, J. (2006). Pooling experiments for blood screening and drug
discovery. In Screening: Methods for Experimentation in Industry, Drug
Discovery, and Genetics, edited by Dean, A. and Lewis, S., New York:
Springer.
Kainkaryam, R. and Woolf, P. (2009). Pooling in high-throughput drug
screening. Current Opinion in Drug Discovery and Development 12, 339–350.
Kim, H., Hudgens, M., Dreyfuss, J., Westreich, D., and Pilcher, C. (2007).
Comparison of group testing algorithms for case identification in the presence
of test error. Biometrics 63, 1152-1163.
Kim, H. and Hudgens, M. (2009). Three-dimensional array-based group testing
algorithms. Biometrics 65, 903-910.
Litvak, E., Tu, X., and Pagano, M. (1994). Screening for the presence of a
disease by pooling sera samples. Journal of the American Statistical
Association 89, 424-434.
Liu, S., Chiang, K., Lin, C., Chung, W., Lin, S., and Yang, T. (2011). Cost
analysis in choosing group size when group testing for Potato virus Y in the
presence of classification errors. Annals of Applied Biology 159, 491–502.
Liu, A., Liu, C., Zhang, Z., and Albert, P. (2012). Optimality of group testing in
the presence of misclassification. Biometrika 99, 245-251.
Louis, T. (1982). Finding the observed information matrix when using the EM
algorithm. Journal of the Royal Statistical Society, Series B 44, 226-233.
Mund, M., Sander, G., Potthoff, P., Schicht, H., and Matthias, K. (2008).

33
Introduction of Chlamydia Trachomatis screening for young women in
Germany. Journal der Deutschen Dermatologischen Gesellschaft 6, 1032-1037.
Muñoz-Zanzi, C., Johnson, W., Thurmond, M., and Hietala, S. (2000). Pooledsample testing as a herd-screening tool for detection of bovine viral diarrhea
virus

persistently

infected

cattle.

Journal

of

Veterinary

Diagnostic

Investigation 12, 195–203.
Neuhaus, J. (1999). Bias and efficiency loss due to misclassified responses in
binary regression. Biometrika 86, 843-855.
Phatarfod, R. and Sudbury, A. (1994). The use of a square array scheme in blood
testing. Statistics in Medicine 13, 2337-2343.
Priddy, F., Pilcher, C., Moore, R., Tambe, P., Park, M., Fiscus, S., Feinberg, M.,
and Rio, C. (2007). Detection of acute HIV infections in an urban HIV
counseling and testing population in the United States. Journal of Acquired
Immune Deficiency Syndromes 44, 196-202.
Sobel, M. and Elashoff, R. (1975). Group testing with a new goal, estimation.
Biometrika 62, 181-193.
Sobel, M. and Groll, P. (1959). Group testing to eliminate efficiently all
defectives in a binomial sample. The Bell System Technical Journal 38, 11791252.
Stramer, S., Glynn, S., Kleinman, S., Strong, D., Caglioti, S., Wright, D., Dodd,
R., and Busch, M. (2004). Detection of HIV-1 and HCV infections among
antibody-negative blood donors by nucleic acid–amplification testing. New
England Journal of Medicine 351, 760-768.
Swallow, W. (1985). Group testing for estimating infection rates and probabilities
of disease transmission. Phytopathology 75, 882-889.
Tecan Group Ltd. (2007). Automated blood pooling ensures safe PCR
diagnostics. Tecan Journal 3, 14-15.
Thierry-Mieg, N. (2006). Pooling in systems biology becomes smart. Nature
Methods 3, 161-162.
Tilghman, M., Guerena, D., Licea, A., Perez-Santiago, J., Richman, D., May, S.,
and Smith, D. (2011). Pooled nucleic acid testing to detect antiretroviral

34
treatment failure in Mexico. Journal of Acquired Immune Deficiency
Syndromes 56, 70-74.
Vansteelandt, S., Goetghebeur, E., and Verstraeten, T. (2000). Regression models
for disease prevalence with diagnostic tests on pools of serum samples.
Biometrics 56, 1126-1133.
Xie, M. (2001). Regression analysis of group testing samples. Statistics in
Medicine 20, 1957-1969.

Table 2.1. The numerator and denominator for ik for the halving protocol in Section 2.2.3. To simplify the expressions,

qik  1  pik and ik(y )  P (Yik  yik | Yik  yik ) are used, and we assume individual i is within subgroup k1.
ik

Scenario Numerator

Denominator

(1  )pik

1  ik

2




(1  )pik   qi k  (1  ) 1   qi k 


 i k 2
i k 2
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2 (1  )  qi k  (1  )   qi k  1   qi k  
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i 1
i k 2





2
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i k 2 



i k 1
i k 1
i k 2

3



2 pik ik(1)    i(ykik )P (Yi k  yi k ) 

yi ,k 1 i k 1,i i
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k q
k q
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2    i(ykik )P (Yi k  yi k )   qi k  
i k 2 
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2 (1  )    i(ykik )P (Yi k  yi k ) 1   qi k 



i k 2
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 i k 1 
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k q
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Table 2.2. Parameter estimates and their standard errors based on 1000 (300 for
array testing) simulated data sets with 0 = -7, 1 = 0.1, and  =  = 0.99. The
mean row includes the averaged estimate across all simulated data sets. The
SE/SD row gives the averaged standard error over all simulated data sets (SE)
divided by the sample standard deviation of the estimates across all data sets
(SD).

I=4

̂0

̂1

Mean

-7.003

SE/SD
IG
Dorfman
Halving
Array w/o retesting
Array w/ retesting

I = 20

̂0

̂1

̂0

̂1

0.099

-7.013

0.099

-7.016

0.099

0.983

0.977

0.970

0.966

1.002

0.987

Mean

-6.918

0.096

-6.840

0.091

-6.628

0.081

SE/SD

0.961

0.948

0.886

0.854

0.861

0.840

Mean

-6.995

0.099

-7.013

0.100

-6.983

0.099

SE/SD

1.002

1.008

0.982

0.982

0.978

0.980

Mean

-7.000
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-7.015

0.099

-7.021

0.098

SE/SD

1.016

1.020

0.982

0.982

0.978

0.973

Mean

-7.024
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-6.984

0.099

-7.023

0.099

SE/SD

1.007

1.044

0.981

0.997

0.989

0.991

Mean

-7.022

0.100

-7.010

0.100

-7.018

0.099

SE/SD

0.982

1.017

1.001

1.011

0.979

0.979

Protocol
Individual

I = 12
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Table 2.3. Parameter estimates and estimated standard errors for the chlamydia
screening data. The “p-value” column gives Wald test p-values for testing
whether or not a regression parameter is equal to 0. Note that an overall test is
performed for all levels of the variable Race. The number of tests performed by
each protocol is in parenthesis after the protocol name.

Individual (6139)
Term

Estimate SE

p-value

IG (1228)
Estimate SE

Dorfman (3458)

p-value

Estimate SE

p-value

Intercept

-2.46

0.24 <0.001

-2.52

0.36 <0.001

-2.16

0.20 <0.001

Age

-0.03

0.01 <0.001

-0.03

0.01

0.061

-0.04

0.01 <0.001

Race level #1

0.79

0.15 <0.001

0.79

0.26

0.017

0.67

0.12 <0.001

Race level #2

0.80

0.32

0.88

0.50

1.08

0.25

Race level #3

0.44

0.26

0.43

0.50

0.37

0.22

Symptoms

0.45

0.16

0.32

0.30

0.285

0.69

0.14 <0.001

Urethritis

1.29

0.33 <0.001

1.40

0.51

0.006

0.95

0.33

0.004

Multiple partners

0.44

0.19

0.019

0.56

0.33

0.090

0.53

0.16

0.001

New partner

0.17

0.20

0.407

0.11

0.40

0.782

0.10

0.18

0.567

Contact to a STD

1.04

0.15 <0.001

1.12

0.27 <0.001

1.10

0.14 <0.001

0.004

Array w/o retesting
Halving (2898)
Term

Estimate SE

p-value

(1541)
Estimate SE

Array w/ retesting (3097)
p-value

Estimate

SE

p-value

Intercept

-2.39

0.22 <0.001

-2.56

0.34 <0.001

-2.11

0.21

<0.001

Age

-0.04

0.01 <0.001

-0.03

0.01

-0.05

0.01

<0.001

Race level #1

0.64

0.14 <0.001

0.94

0.23 <0.001

0.73

0.12

<0.001

Race level #2

0.47

0.34

0.28

0.59

0.39

0.33

Race level #3

0.68

0.22

0.24

0.44

0.49

0.21

Symptoms

0.63

0.15 <0.001

0.64

0.23

0.005

0.71

0.14

<0.001

Urethritis

1.07

0.34

0.002

0.61

0.53

0.254

0.96

0.35

0.006

Multiple partners

0.35

0.16

0.029

0.56

0.30

0.062

0.45

0.17

0.008

New partner

0.11

0.20

0.600

0.22

0.36

0.549

0.29

0.18

0.100

Contact to a STD

1.16

0.15 <0.001

1.26

0.21 <0.001

1.04

0.14

<0.001

0.013
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Figure 2.1. Relative efficiencies calculated by Equation (6) based on 500
simulated data sets. Dorfman and halving protocols are compared to IG. Array
testing is compared with and without retests.
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Figure 2.2. Averaged Var (ˆ1 ) for 500 simulated data sets. The dashed horizontal
line corresponds to Var (ˆ1 ) from individual testing. The right-side plots are the
same as those on the left-side except we omit IG in order to reduce the y-axis
scale.
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Figure 2.3. Average number of tests per unit of information calculated by
Equation (7) based on 500 simulated data sets.
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Chapter 3: Paper #2 - Regression Analysis for
Multiple-Disease Group Testing Data
Abstract
Group testing, where groups of individual specimens are composited to test for
the presence of a disease (or other binary trait), is a procedure commonly used to
reduce the costs of screening a large number of individuals. Group testing data
are unique in that only group responses may be observed, but inferences are
needed at the individual level. A further methodological challenge arises when
individuals are tested in groups for multiple diseases simultaneously, because the
unobserved individual disease statuses are likely to be correlated. In this paper,
we propose the first regression techniques for multiple-disease group testing data.
We develop an expectation-solution based algorithm that provides consistent
parameter estimates and natural large-sample inference procedures. Our proposed
methodology is applied to chlamydia and gonorrhea screening data collected in
Nebraska as part of the Infertility Prevention Project.

KEY WORDS: Correlated binary data; Expectation-solution algorithm; Generalized
estimating equations; Latent response; Pooled testing; Unobserved response.
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3.1 Introduction
Researchers are often interested in modeling the disease infection status of
individuals to identify important risk factors and to estimate subject-specific risk
probabilities. In many cases, pooling specimens (e.g., blood, urine, swabs, etc.)
through group testing offers a novel approach to significantly reduce the number
of tests, the time expended, and the overall costs. These practical benefits have
led to the adoption of group testing in a number of infectious disease
applications, including blood donation screening by the American Red Cross
(American Red Cross, 2012), opportunistic chlamydia and gonorrhea testing in
medical clinics (Gaydos, 2005), and Bovine Viral Diarrhea virus detection for the
cattle industry (Munoz-Zanzi et al., 2006). Group testing has also proven to be
beneficial in other areas including pharmaceutical drug discovery (Remlinger et
al., 2006), plant pathology (Tebbs and Bilder, 2004), genotyping (Chi et al.,
2009), and food contamination testing (Fahey, Ourisson, and Degnan, 2006).
Statistical research in group testing has traditionally focused on estimating the
prevalence of disease in a homogeneous population. More recently, research has
shifted towards incorporating individual covariate information to produce
individual-specific estimates in a regression context. Vansteelandt, Goetghebeur,
and Verstraeten (2000) and Xie (2001) are commonly regarded as the seminal
papers in this area. Vansteelandt et al. (2000) provides a generalized linear model
regression approach that uses only the initial group responses for estimation.
Xie’s (2001) approach is more flexible by allowing for different classes of
regression models and the inclusion of additional information from retesting
subsets of positive groups. Several very recent papers have expanded on the work
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of Vansteelandt et al. (2000) and Xie (2001). Specifically, Bilder and Tebbs (2009)
provide a thorough comparison of individual and group testing regression model
estimates, Chen, Tebbs, and Bilder (2009) examine mixed-effects models, Delaigle
and Meister (2011) and Delaigle and Hall (2012) formulate a nonparametric
modeling approach. Group testing regression models even have been used to
diagnose model misspecification with individual response data, as illustrated by
Huang (2009).
When viewed collectively, research in group testing regression modeling has
one notable shortcoming; namely, the available methodology involves only singledisease models. However, in many screening applications, testing is performed not
for one disease but for multiple diseases at the same time – often using the same
assay. For example, the American Red Cross uses group testing to screen millions
of blood donations per year for HIV, hepatitis B, and hepatitis C with a single
assay (Stramer et al., 2004; American Red Cross, 2012). Also, as part of the
nationally implemented Infertility Prevention Project, the Nebraska Public
Health Laboratory (NPHL) uses the GenProbe Aptima Combo 2 assay to test
thousands of individual specimens each year for chlamydia and gonorrhea
simultaneously. Despite the ubiquity of multiple-disease screening in practice,
Hughes-Oliver and Rosenberger (2000) is the only paper that has addressed the
multiple-disease problem in the group testing literature, and they do so assuming
that the population is homogeneous and that diagnostic tests are perfect.
The purpose of our paper is to develop new group testing regression models for
multiple-disease screening data in heterogeneous populations with imperfect
diagnostic tests. In essence, our research deals with modeling correlated binary
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data, but with the unique aspect that the underlying disease responses are
unobserved for each individual. Broadly speaking, our paper can be viewed as a
generalization of Vansteelandt et al. (2000) and Xie (2001) to model multipledisease statuses and, at the same time, a generalization of Hughes-Oliver and
Rosenberger (2000) to incorporate covariate information and imperfect diagnostic
tests.
The remainder of this paper is organized as follows. Section 3.2 describes the
notation and states the model of interest. Section 3.3 shows how the expectationsolution (ES) algorithm of Elashoff and Ryan (2004) can be used to model
multiple-disease statuses with group testing responses. Due to the complicated
relationship between the unobserved individual and observed group responses
when diagnostic testing error is present, we develop new ways to approximate the
true correlation structure among the unobserved individuals. Section 3.4 presents
simulation evidence demonstrating that parameter estimates are consistent and
that Wald confidence intervals achieve their stated confidence levels in realistic
settings. Section 3.5 applies this work to the chlamydia and gonorrhea screening
data from the NPHL. Finally, Section 3.6 summarizes this work and suggests
future areas of research.

3.2 Notation and Model
Define Yijk as the true unknown individual status of disease j for the ith individual
in group k, where i = 1, …, Ik, j = 1, …, J, k = 1, …, K, and suppose that these
random variables are independent across i and k. The value for Yijk is 0 for a
negative response and 1 for a positive response; we use this standard convention
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for all subsequently defined binary random variables. For each individual i,

Yik  (Yi 1k , ..., YiJk ) contains J unobserved disease statuses that are likely
correlated.
Define Zjk as the observed group binary response for the jth disease and the kth
group. We assume that all groups are non-overlapping and that each individual is
within one group. If group tests are perfectly accurate, as assumed in HughesOliver and Rosenberger (2000), Zjk = 1 if and only if
and only if



Ik



Ik

Yijk  0 and Zjk = 0 if

i 1

Yijk  0 . Of course, assays are unlikely to be perfect in practice,

i 1

so one must account for this uncertainty. For disease j, define the group test
sensitivity and specificity as j  P (Z jk  1 | Zjk  1) and j  P (Z jk  0 | Zjk  0),
respectively, where Zjk denotes the true group binary response for disease j and
group k. We assume the sensitivity and specificity are known for each disease and
are not dependent on pool size; these assumptions are analogous to those made
by Vansteelandt et al. (2000) and Xie (2001) for single-disease group testing
regression models and by Neuhaus (1999, 2002) for individual testing regression
models. We can then express jk ≡ P(Zjk = 1) in terms of the true individual
probabilities P (Yijk  1)  pijk as

jk  P (Z jk  1 | Zjk  1)P (Zjk  1)  P (Z jk  1 | Zjk  0)P (Zjk  0)
Ik

 j  (1  j  j ) (1  pijk ).
i 1

(8)

With covariates xik  (x1ik , ..., x p1,ik ) collected on each individual, our goal is to
estimate pijk when only the observed group responses Zjk are available, similar to
Vansteelandt et al. (2000) with single-disease models. In all subsequent
expectations written in this chapter, we condition on the full set of covariates xik
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as we did for pijk , but we suppress this specification for notational simplicity. We
consider models of the form

f (pijk )  0 j  1 j x1ik    p1, j x p1,ik ,

(9)

where f(×) is a known monotonic, differentiable function and rj (r = 0, …, p – 1,
j = 1, …, J) is a regression parameter. Using a joint model, as in Equation (9),
not only enables one to analyze group testing data as they naturally arise from
multiple-disease screening assays, but it also allows one to incorporate the withinindividual correlation across the J diseases. We demonstrate in Section 3.4 that
our joint modeling approach in realistic settings provides more efficient regression
estimators than using J separate single-disease group testing models. This is
because separate modeling discards important information about how the J
disease statuses are related.

3.3 Expectation-Solution Algorithm
The ES algorithm, introduced by Elashoff and Ryan (2004), is a generalization of
the expectation-maximization (EM) algorithm given by Dempster et al. (1977).
The algorithm iterates between two steps: the E-step, which computes the
expectation of the complete data given the observed data, and the S-step, which
substitutes the expected values into the complete-data estimating equations and
solves the equations for the model parameters. The generalization given in
Elashoff and Ryan (2004) allows these estimating equations to take on a variety
of forms, including generalized estimating equations. We utilize the ES algorithm
by treating the unobserved individual responses in group testing as “missing” and
modify the algorithm to estimate Equation (9) using the observed group
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responses. Our application of the ES algorithm requires additional work to
estimate the correlation among the unobserved individual responses, as shown in
Section 3.3.2.
3.3.1 Estimating Equations
To explain our model fitting approach, consider the hypothetical situation where
the true individual responses Yijk are observed and standard generalized
estimating equation (GEE) methodology is used to estimate the model in
Equation (9). Let R(), where  = (1, 2, …, S), denote the J  J working
correlation

matrix

for

the

true

individual

responses.

Define

Cov(Yik )  Vik  Bik1/2R()Bik1/2 where Bik  Diag pijk (1  pijk ). The estimating

equations are

(, )    ik (, )    DikVik1(yik  pik )  0,
k

i

k

where   (01, ..., p1,1, 02 , ..., p1,J ) ,

yik

is

a

realization

of Yik ,

(10)

i

0

is

Dik  ( / )pik , pik  (pi 1k , ..., piJk ) ,

a

pJ

×

1

vector

of

0’s,

and

ik (, )  DikVik1(yik  pik ) is the contribution of the ith subject in the kth group

to the estimating equations. If realizations of the individual responses Yijk were
available, parameter estimates would be found by successively estimating  and
solving Equation (10) for  in an iterative manner until convergence.
Because the individual responses Yijk are not observed in group testing, we can
not use standard GEE methodology as stated above. However, analogous to the
use of the expectation-maximization (EM) algorithm approach described in Xie
(2001) for a single disease, we can replace the individual responses in Equation
(10) by their expected values, conditional on the group responses Z = (Z1k, …,
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ZJK). Because a conditional expectation involving Yijk depends only on its
corresponding group response, it suffices to calculate E (Yijk | Z jk  1)  j pijk / jk
and E (Yijk | Z jk  0)  (1  j )pijk / (1  jk ) . Replacing yijk with E (Yijk | z jk ) ,
Equation (10) becomes

 obs (, )    ikobs (, )    DikVik1(ik  pik )  0,
k

i

k

(11)

i

ik ).
where ik  (E (Yi 1k | z1k ), ..., E (YiJk | zJk )) and ikobs (, )  DikVik1(ik  p

The symbol  obs indicates that Equation (11) no longer involves any unknown
individual responses. The ES algorithm successively estimates  and solves
Equation (11) for  in an iterative manner to obtain parameter estimates. The
initial estimate of  can be found by estimating separate models for each disease
with the methodology in Xie (2001). Note that the expectations E (Yijk | z jk ) are
updated at each iteration to correspond to the current estimate of . Estimating
 at each iteration is not straightforward, so we discuss it thoroughly in the next
subsection. The final iterative solution to Equation (11) at convergence is the
estimate of , which we denote by ̂ .
3.3.2 Correlation Estimation
To estimate , we need to first identify the relationship between Cov(Z jk , Z j k ) ,
which we can estimate from the observed group responses, and Corr (Yijk ,Yij k ) ,
which involves the unobserved individual responses. This relationship is given in
the following theorem.
THEOREM 1: Assuming that the observed group responses are independent given
the true group statuses, the covariance between Z jk and Z j k , when written as a
function of the correlation of the unknown individual responses, is
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 Ik
Cov(Z jk , Z j k )  jj    Corr (Yijk ,Yij k ) Var (Yijk )Var (Yij k )  (1  pijk )(1  pij k ) 
i 1
Ik

(12)
 (1  pijk )(1  pij k )

i 1





for 1 ≤ j, j ≤ J and k = 1, …, K, where jj   (j  j  1)(j   j   1) .
The proof of Theorem 1 is given in Appendix G. The importance of Theorem 1
is that it provides a convenient way to obtain method of moments estimates for

Corr (Yijk ,Yij k ) . Suppose an estimate of the model given in Equation (9) is
available so that we can then estimate jk, denoted by ˆjk , through Equation (8).
Define rˆjk  z jk  ˆjk as residuals from the model’s fit, where zjk is the realization of
Zjk. After replacing Cov(Z jk , Z j k ) with rˆjk rˆj k in the left-hand side of (12), we
create one equation for each s (s = 1, …, S). We argue in Appendix H that one

ˆ  (ˆ1, ..., ˆS ) is a
unique solution ˆs can be found in each equation and that 
consistent estimator of  when  is known.
To illustrate this approach, suppose that there is an exchangeable correlation
structure between Yijk and Yij k , say, Corr (Yijk ,Yij k )   , so that S = 1. The
estimate of  is obtained by solving
K
K
 Ik
  rˆjk rˆj k    jj     pˆijk (1  pˆijk )pˆij k (1  pˆij k )  (1  pˆijk )(1  pˆij k ) 
i 1
k 1 j  j 
k 1 j  j 
Ik

(13)
 (1  pˆijk )(1  pˆij k )

i 1





ˆ is the model’s estimate of p . Alternatively, if one specifies an
for , where p
ijk
ijk

unstructured correlation matrix so that Corr (Yijk ,Yij k )  jj  , for j  j, we
obtain J(J – 1)/2 equations of the form
K
K  Ik
 rˆjk rˆj k  jj     jj  pˆijk (1  pˆijk )pˆij k (1  pˆij k )  (1  pˆijk )(1  pˆij k ) 
k 1
k 1 i 1
Ik

(14)
 (1  pˆijk )(1  pˆij k )

i 1
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The (j, j)th element of R() can be estimated by solving Equation (14) for jj  .
Estimation for other correlation structures is performed in a similar manner.
Because Cov(Z jk , Z j k ) is a polynomial function of Corr (Yijk ,Yij k ) of degree Ik,
obtaining the coefficients for this function can be computationally expensive
when the group size Ik is large. Fortunately, we have found that the higher order
(≥ 3) coefficients of Corr (Yijk ,Yij k ) are almost always negligible. As a result, it
usually suffices to use the linear and quadratic terms to estimate . For example,
for an unstructured working correlation matrix, the linear and quadratic
coefficients of jj  in (13) are computed as
ˆijk p
ˆij k
Ik
 Ik
p

ˆijk )(1  p
ˆij k )
cˆjj ,k  jj  
  (1  p

ˆijk )(1  p
ˆij k )


i 1
 i 1 (1  p



and

 Ik

dˆjj ,k  jj    (1  pˆijk )(1  pˆij k ) 
i 1

pˆi1 jk pˆi1 j k
pˆi2 jk pˆi2 j k

1i1 i2 Ik
(1  pˆi1 jk )(1  pˆi1 j k ) (1  pˆi2 jk )(1  pˆi2 j k )
ˆjj  solves
respectively. The estimate 
K

K

k 1

k 1

 rˆjk rˆj k   cˆjj ,k ˆjj 

using a first-order approximation or
K

K

K

k 1

k 1

k 1

2
 rˆjk rˆj k   cˆjj ,k ˆjj    dˆjj ,k ˆjj 

using a second-order approximation. More details on these approximations,
including their derivations and accuracy, are available in Appendix I.
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3.3.3 Model Fitting Algorithm
We propose the following ES algorithm to obtain parameter estimates when
modeling multiple diseases with group testing data:
1) Select initial values (0) of .
2) E-Step:

For

a

given

(b ) ,

b

=

0,

1,

2,

…,

calculate

ik(b )  (E (Yi 1k | z1k , (b ) ), ..., E (YiJk | zJk , (b ) )) , i = 1, …, Ik and k = 1, …, K.

3) S-Step: Estimate  using the methods in Section 3.3.2 with the current
estimate (b ) , and denote it as 
ˆ((b ) ). Solve

ˆ((b ) ))    DikVik1(ik(b )  pik )  0
 obs (, 
k

i

for  to update the parameter estimates at the (b + 1)th iteration, where

ˆ((b ) ) within Vik and ik(b ) are treated as fixed and known.

4) Repeat Steps 2 and 3 until (b 1)  (b ) is very small; denote the final
solution by ̂ .
3.3.4 Variance Estimation
Elashoff and Ryan (2004) showed that under certain regularity conditions,
regression parameter estimators obtained from the ES algorithm are consistent
and are asymptotically normal. Consistency and asymptotic normality also hold
ˆ) . Note that for each
in our setting but with a small change to the form of Cov(

group k, the expectations E (Y1 jk | Z jk ), ..., E (YI

k

jk

| Z jk ) are all functions of Zjk;

thus the ik (, ) expressions in the same group are dependent. It is therefore
necessary to modify the middle part of the sandwich variance estimator in
Elashoff and Ryan (2004) to incorporate this within group dependence.
Specifically, the covariance matrix of ̂ is

52
1


ikobs (, )

ˆ

Cov()   


 k i


 

obs
obs
   (, )  ik (, )  
 k i ik
i









1

obs


  ik (, ) ,

 k i




(15)

ik are all functions of . An estimate of this
where , Dik, Vik, ik, and p
 (
ˆ) , arises from evaluating Equation
covariance matrix, which we denote by Cov

(15) at ̂ and ̂ . Our simulation evidence in Section 3.4 shows that standard
 (
ˆ) and that
errors are well estimated by the corresponding entries in Cov

resulting Wald confidence intervals confer the nominal level in realistic settings.

3.4 Simulation Evidence
We have extensively examined via simulation the performance of our proposed
methodology in realistic group testing settings. For illustration, consider a logistic
regression model for two diseases and two covariates:

logit(pijk )  0 j  1 j x1ik  2 j x2ik

(16)

for j = 1, 2, where the between-disease correlation is Corr (Yi 1k ,Yi 2k )  . We
simulate the first covariate x1ik from a Uniform(0, 1) distribution and the second
covariate x2ik from a gamma(17, 1.4) distribution. The true regression parameters
chosen are 01 = -6, 02 = -7, 11 = 0, 12 = 1, 21 = 0.1, and 22 = 0.1. These
covariate

and

parameter

configurations

provide

a

mean

prevalence

of

approximately 3% for the first disease and 2% for the second disease, which are
at typical prevalence levels where group testing would be used. In Appendix J,
we provide histograms of the true individual probabilities for a simulated data set
under this model.
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We employ the following strategy to simulate the group responses Zjk for j = 1,
2 and k = 1, …, K. With the individual probabilities from Equation (16) and a
given value of , we use the correlated binary data generation procedure of
Emrich and Piedmonte (1991) to simulate the (Yi 1k ,Yi 2k ) responses. These
responses are then randomly assigned to groups. The true, unobserved group
responses Zjk are obtained using Zjk  1 if



Ik



Ik

Yijk  0 and Zjk  0 if

i 1

Yijk  0 for disease j and group k. Allowing for testing error, the observed

i 1

group test responses Zjk are then simulated from the appropriate Bernoulli
distribution with success probability j = j = 0.95 for j = 1, 2.
The ES algorithm with a second-order approximation is used to estimate 
and Equation (16) for each of B = 1000 simulated data set, where we estimate
only one parameter, say 2, for both 21 = 22 because these two parameters are
assumed to be equal. This is motivated by our analysis of the NPHL data in
Section 3.5, in which the hypothesis of sharing parameters across diseases for a
certain covariate (i.e., across the levels of j) is not rejected. Table 3.1 gives the
parameter estimates averaged over 1,000 simulated data sets for various
combinations of , K, and Ik (“Mean” row). The use of large samples sizes (K >
500) is motivated by our experience with the NPHL (see Section 3.5). As
expected, the regression parameter estimates on average approach their
corresponding parameters as K increases. We also calculate the standard
deviation (SD) for each regression parameter estimate across the 1,000 simulated
data sets and compare this to the corresponding averaged estimated standard
error (SE) that would be obtained from (15). Also as expected, the SE/SD ratio
given in Table 3.1 approaches 1 as K increases, although the SE is slightly
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underestimated for smaller K. Lastly, in Table 3.1, we give the estimated
coverage levels of 95% Wald confidence intervals for each regression parameter.
These levels are all between 0.94 and 0.96, which indicate the intervals are
performing as expected.
It is often of interest to see how the standard errors of joint modeling of all
diseases using the ES algorithm compare to fitting separate group testing models
to each disease using the method of Vansteelandt et al. (2000). To explore this,
we calculate the relative efficiency as

1 B Var (ˆbML
,rj )
ES
ML
ˆ
ˆ
RE(b,rj to b,rj )  
,

ES
B b 1 Var (ˆb,rj )

(17)

th
ˆES
where ˆbML
regression parameter estimate for the jth
,rj and b ,rj denote the r

disease using the Vansteelandt et al. (2000) approach and ES algorithm,
respectively. Table 3.2 displays the relative efficiencies for the same simulated
(ˆES )
data in Table 3.1. Note that we calculate the relative efficiency using Var
b ,2

when r = 2 because the single parameter 2 replaces 21 = 22. For relative
efficiencies involving ˆbES
,2 , dramatic increases in efficiency are seen in Table 3.2
with levels at times greater than 2. In addition, even when parameters are not
shared for r = 1, we still see valuable gains in efficiency ranging from 1.4% to as
high as 17.2%. To compare all regression estimators for each j, we also include in
Table 3.2 the relative efficiency as in Equation (17), but now involving
(logit(pˆ )) where p̂ denotes the estimated probability of disease positivity at
Var
b

the mean values of the two covariates in Equation (16). Again, we see the
benefits of joint modeling with gains in efficiency ranging from 16.3% to 43.1%.
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We have performed a number of additional simulations using different models,
different prevalence levels, and different levels of correlation among diseases.
Details for these simulations are provided in Appendix J. For example,
corresponding to Equation (17), we have also calculated the relative efficiencies
where 21 and 22 are estimated separately. It is not surprising that the relative
efficiencies in this situation are smaller, but they are still as large as 11%.

3.5 Applications
Chlamydia and gonorrhea are the two most prevalent sexually transmitted
diseases reported in the United States (Centers for Disease Control and
Prevention, 2010). This is true in Nebraska as well, and these diseases even have
been characterized as being at epidemic levels in Omaha (Zagurski, 2006). As
part of the Centers for Disease Control and Prevention funded Infertility
Prevention Project (IPP), the NPHL uses a single assay to test for chlamydia
and gonorrhea simultaneously. Due to the high cost incurred by their use of
individual testing (approximately $11 for a swab test and $16 for a urine test)
and the large numbers of individuals tested (approximately 25,000 per year), the
NPHL is interested in using group testing for screening. A few other laboratories,
such as the State Hygienic Laboratory at the University of Iowa, already use
group testing as part of their participation in the IPP. Our goal is to fit models
that can estimate an individual’s probability of having chlamydia or gonorrhea
using group testing responses. This would enable our medical colleagues at the
NPHL to understand how these disease statuses are related to certain risk factors
at a fraction of the cost when compared to testing subjects individually.
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Furthermore, the models could also provide additional insight on how to retest
individuals in positive groups if identification of positive and negative individuals
was our goal (Bilder, Tebbs, and Chen 2010a).
We focus on the 14,530 female swab specimens that were tested individually
by the NPHL in 2009. The overall prevalence for chlamydia and gonorrhea
during this year was approximately 0.069 and 0.013, respectively (unadjusted for
potential testing error). We construct groups of size 5 with the observed data by
assigning individuals to groups based on specimen arrival date. Groups of this or
of similar size are used elsewhere for chlamydia and gonorrhea screening; see
Morre et al. (2001) and Butylkina et al. (2007). The NPHL’s assay for female
swabs has a sensitivity of 0.928 for chlamydia and 0.966 for gonorrhea and a
specificity of 0.960 for chlamydia and 0.980 for gonorrhea. We use these same
levels in our analysis here. In addition to the testing outcomes for both infections,
the NPHL collects additional covariate information on each individual.
Specifically, we use the following covariates in our models: age, race (represented
by three indicator variables), symptoms, clinician observation variables (cervical
friability, pelvic inflammatory disease, cervicitis), and risk history variables
(multiple partners, new partner in the last 90 days, contact with someone who
has a sexually transmitted disease). All covariates are dichotomous (0 and 1)
except for age.
Table 3.3 displays the results from fitting a first-order model using our
methodology in Section 3.3 with a logit link function. The estimated value of  is
0.27, which is obtained through using a second-order approximation for it (see
Section 3.3.2). For comparison purposes, we also fit the same regression model
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using the individual observations with standard GEE methodology. This is why
we use data that were originally collected on each individual; otherwise, it would
not be possible to make this type of comparison. When we fit the individual
testing model, we assume that the assay sensitivity and specificity are equal to 1.
We attempted to fit this model using the GEE methodology of Neuhaus (2002),
which allows for imperfect sensitivity and specificity, but many of the parameter
estimates associated with gonorrhea infections did not converge. A further
investigation on our part revealed that this is caused by a low gonorrhea
prevalence at the given specificity level. In fact, the maximum likelihood estimate
for the overall gonorrhea prevalence is actually negative.
The parameter estimates given in Table 3.3 for the group and individual
testing models are often in close agreement. The estimated standard errors
associated with individual testing are lower than those of the group testing
models. This is expected because there are five times more observations used to
fit the individual testing model; see Vansteelandt et al. (2000) and Bilder and
Tebbs (2009) for a similar discussion with single-disease group testing models.
However, it is interesting to note that the group testing standard errors are only
1.3 to 3.2 times more than the individual testing standard errors.
Using a 0.05 level of significance with the group testing models, Wald test pvalues (not shown) are less than 0.05 for the covariates:
•

Race,

symptoms,

multiple

partners,

and

contact

to

a

STD

corresponding to gonorrhea, and
•

Age, race, symptoms, cervicitis, and contact to a STD corresponding to
chlamydia.
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In this assessment, we perform one test jointly for the four race levels. These
results largely agree with those from fitting the individual testing model,
although the individual testing analysis finds some additional parameters
significant at the 0.05 level (age, pelvic inflammatory disease, and cervicitis for
gonorrhea).
Using our group testing model, it is possible to perform hypothesis tests of the
form H 0 : r 1  r 2 versus Ha : r 1  r 2 for r = 0, 1, …, p – 1; i.e., we can test
for a common parameter across diseases. It is important to emphasize that these
tests can not be performed using single-disease group testing regression models,
because parameters are estimated separately for each infection. The following
covariates have large Wald test p-values using the group testing model: pelvic
inflammatory disease (p-value = 0.642), new partner (p-value = 0.533), cervicitis
(p-value = 0.516), and cervical friability (p-value = 0.466). In the light of these
findings, it may be reasonable to consider a more parsimonious model with a
shared parameter across both diseases for these covariates. When we estimate
this model (see Appendix K), we find that Wald test p-values are generally less
than 0.05 for the same covariates as before. The only difference is that the
significant parameter for cervicitis is now shared across the infections.

3.6 Discussion
In this chapter, we have developed a group testing regression model based on the
ES algorithm for correlated multiple-disease data. Specifically, our proposed
method takes advantage of covariate information in estimating individual
statuses of multiple diseases simultaneously in a group testing setting. Also, our
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methods are especially useful when comparisons of model parameters across
diseases are desired. R functions are created for implementing this procedure and
are available at www.chrisbilder.com/grouptesting/multiple. In the
future, we intend to include the functions in R’s binGroup package (Bilder et al.
2010b; R Development Core Team 2012).
We also derived another approach (called “GEE-group”) for modeling
correlated multiple-diseases, where we focus on the observed group responses
Zk  (Z 1k , , Z jk ) and solve the estimating equations written in terms of Z =

(Z1, …, ZK). This method can be viewed as a direct generalization of the
Vansteelandt et al. (2000) approach for single-disease group testing models. GEEgroup produces estimates close to those given by the ES algorithm. However, this
method has a couple of clear drawbacks that would keep us from using it. First,
the working correlation structure must be specified in terms of group responses,
which is far less natural than being specified through individual responses like in
the ES algorithm. Second, the GEE-group approach cannot be generalized to
incorporate any retesting information while we expect the ES algorithm-based
method could be generalized (see the last paragraph). More details on our
investigation into the GEE-group approach can be found in Section 4.5.
If we let the j subscript in our notation represent time points rather than
different diseases, our proposed method is directly applicable to a single-disease
longitudinal testing setting. This modeling approach restricts individual subjects
to be within the same groups over time. We tried to relax this restriction by
allowing individuals to appear in different groups at different time points, but we
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found it is mathematically quite difficult because Zjk now could be correlated with

Z j k  for any k (i.e., responses are correlated across groups).
Using only the group responses, our proposed method can estimate covariateadjusted individual probabilities with reduced cost. When further identification of
positive individuals is needed, retesting individuals (or subsets of individuals)
from positive groups is often performed. Future research should examine how to
incorporate the individual retest outcomes into the estimation process. We expect
these additional responses will lead to improved parameter estimates. Our ES
algorithm-based approach most likely could accommodate these situations by
taking into account the retests in the conditional expectations of the E-step. For
some retesting schemes, these conditional expectations may not be available in
closed form, but the Gibbs sampling technique could be employed to approximate
them. One complication of including the retest results is that for different
diseases we will likely have different positive groups, leading to different groups
of individuals being retested for j = 1, 2, …, J. Consequently, how to effectively
make use of different individual subjects in estimating the within-subject
correlation is challenging and remains a good future research topic.
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Table 3.1. Simulation results from using the ES algorithm to estimate the model
in Equation (16) with 01 = -6, 02 = -7, 11 = 0, 12 = 1, and 2 = 0.1. A secondorder approximation is used to estimate  as described in Section 3.3.2.
Estimated parameters and standard errors are averaged over 1000 simulated data
sets. Estimated coverage probabilities are for nominal 95% Wald confidence
intervals.

 = 0.6, Ik = 5, K = 1000
01
Mean

02

11

12

2

 = 0.6, Ik = 10, K = 500


01

02

11

12

2



-5.99 -7.03 -0.03 1.00 0.10 0.61

-6.14 -7.20

0.00

1.07 0.10 0.61

SE/SD

0.96

0.96

0.98

0.95 0.96

-

0.99

0.97

0.94

0.93 0.95

-

Coverage

0.95

0.94

0.95

0.95 0.95

-

0.94

0.94

0.95

0.95 0.94

-

 = 0.2, Ik = 5, K = 1000
01
Mean

02

11

12

2

 = 0.2, Ik = 10, K = 500


01

02

11

12

2



-6.02 -7.03

0.03

1.02 0.10 0.20

-6.12 -7.21

0.01

1.13 0.10 0.21

SE/SD

0.95

0.95

0.94

0.95 0.96

-

0.97

0.98

0.96

0.96 0.98

-

Coverage

0.94

0.95

0.95

0.95 0.94

-

0.94

0.94

0.95

0.95 0.95

-

 = 0.6, Ik = 5, K = 2000
01
Mean

02

11

12

2

 = 0.6, Ik = 10, K = 1000


01

02

11

12

2



-6.00 -7.02

0.00

1.02 0.10 0.60

-6.01 -7.04

0.04

1.06 0.10 0.60

SE/SD

0.98

1.00

0.95

0.99 1.00

-

0.99

1.00

0.96

0.98 0.99

-

Coverage

0.94

0.94

0.94

0.96 0.95

-

0.95

0.96

0.95

0.95 0.95

-

 = 0.2, Ik = 5, K = 2000
01
Mean

02

11

12

2

 = 0.2, Ik = 10, K = 1000


01

02

11

12

2



-6.02 -7.05

0.01

1.04 0.10 0.20

-6.05 -7.06

0.03

1.03 0.10 0.20

SE/SD

0.97

0.96

1.01

1.00 0.96

-

0.97

1.00

0.96

0.99 0.97

-

Coverage

0.94

0.94

0.96

0.96 0.94

-

0.95

0.94

0.95

0.95 0.95

-
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Table 3.2. Relative efficiency of the variance estimates for the model in Equation
(16). A single parameter 2 is estimated for both 21 = 22 by the ES algorithm.
logit(pˆ)

0.6

0.2

0.6

0.2

K

Ik

̂01

̂02

̂11

̂12

̂21

̂22

j=1

j=2

1000

5

1.249

1.669

1.085

1.067

1.290

2.229

1.211

1.279

500

10

1.287

1.737

1.113

1.172

1.335

2.358

1.287

1.431

1000

5

1.409

1.828

1.049

1.088

1.573

2.598

1.174

1.326

500

10

1.469

1.897

1.079

1.136

1.718

2.817

1.264

1.404

2000

5

1.197

1.575

1.050

1.014

1.237

1.984

1.163

1.224

1000

10

1.242

1.584

1.061

1.074

1.312

1.999

1.218

1.264

2000

5

1.373

1.733

1.016

1.032

1.521

2.411

1.173

1.275

1000

10

1.462

1.758

1.038

1.070

1.655

2.455

1.241

1.340

66

Table 3.3. Parameter estimates and estimated standard errors (in parentheses)
for the NPHL data. The GEE column corresponds to a model fit to the
individual testing responses using GEE methodology.
Term
Intercept

Age

Race level #1

Race level #2

Race level #3

Symptoms

Cervical friability

Pelvic inflammatory disease

Cervicitis

Multiple partners

New partner

Contact to a STD

Disease

ES algorithm

GEE

Gonorrhea

-5.722(0.605)

-4.553(0.327)

Chlamydia

-0.520(0.419)

-0.976(0.147)

Gonorrhea

-0.031(0.021)

-0.040(0.013)

Chlamydia

-0.113(0.019)

-0.088(0.007)

Gonorrhea

2.020(0.359)

1.319(0.173)

Chlamydia

0.591(0.120)

0.392(0.096)

Gonorrhea

0.771(1.080)

0.715(0.336)

Chlamydia

1.062(0.243)

0.691(0.136)

Gonorrhea

0.782(0.857) -0.113(0.425)

Chlamydia

0.036(0.401)

0.057(0.151)

Gonorrhea

1.092(0.384)

0.930(0.175)

Chlamydia

0.385(0.175)

0.287(0.082)

Gonorrhea

-0.194(0.648)

0.325(0.312)

Chlamydia

0.309(0.305)

0.056(0.170)

Gonorrhea

0.283(0.963)

1.158(0.524)

Chlamydia

0.788(0.627)

0.400(0.387)

Gonorrhea

0.293(0.349)

0.550(0.200)

Chlamydia

0.534(0.199)

0.591(0.107)

Gonorrhea

1.167(0.311)

1.046(0.171)

Chlamydia

0.279(0.221)

0.468(0.100)

Gonorrhea

0.292(0.332) -0.086(0.186)

Chlamydia

0.064(0.197) -0.044(0.092)

Gonorrhea

1.381(0.286)

1.170(0.181)

Chlamydia

0.591(0.212)

0.935(0.101)
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Chapter 4: Additional research
4.1 Introduction
In this chapter, we include additional research performed for this dissertation
that did not fit into previous chapters. For single-disease group testing models,
we derived the explicit form of the likelihood function for the Dorfman and
halving protocols, and evaluated the small-sample performance of the likelihood
ratio tests through simulation. We then discuss how to extend the ES algorithm
in Chapter 3 to allow for the presence of individual retests that would arise from
a group testing protocol as mentioned for Section 2.2. For multiple-disease group
testing data, we also consider two alternative approaches other than the ES
algorithm to estimate the model. The first approach uses random effects to
account for the correlation between disease statuses. The second approach
constructs a set of generalized estimating equations in terms of the observed
group responses Zk = (Z1k, Z2k, …, ZJk), rather than in terms of the unobserved
individual responses as shown in Chapter 3. Finally, we provide directions for
future research on group testing regression models.

4.2 Likelihood Function for Dorfman and Halving Protocols
This sub-section derives the likelihood function for the Dorfman and halving
protocol so that a direct maximization of the function can be carried out. A
benefit from direct maximization is that deviance statistics can be formed, which
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subsequently leads to the construction of likelihood ratio tests (LRTs) and
Akaike’s information criterion (AIC) statistics for model comparisons.
For Dorfman’s protocol, using the same notation as defined in Section 2.2, the
joint

probability

for

all

observed

responses

can

be

written

as

P (Y  y, Z1  z1,..., ZK  zK ) , where y is the vector of individual retests within
positive pools. Because groups are independent of each other, the above
probability can be further written as
P (Y  y, Z1  z1,..., ZK  zK )
  P (Y1k  y1k ,...,YIk k  yIk k , Zk  1)   P (Zk  0).
k :Zk 1

k :Zk 0

Hence, the log-likelihood function is

 log(1  k )   log P (Y1k  y1k ,...,YIk k  yIk k , Zk  1),

k :zk 0

k :zk 1

(18)

where k is given by Equation (1). Note that P (Y1k  y1k ,...,YIk k  yIk k , Zk  1) is
the denominator of Equation (23) in Appendix A, where we showed it can be
written as
Ik

1

Ik

   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )    P (Yi k  yi k | Yi k  0)(1  pi k ).
i 1 yi k 0

i 1

(19)
Substituting Equation (19) and Equation (1) into Equation (18), the loglikelihood function for Dorfman’s protocol can be explicitly expressed. A NewtonRaphson procedure can be employed to maximize the log-likelihood with respect
to . The inverse of the observed information matrix can serve as the estimated
covariance matrix of ̂ .
Similarly for the halving protocol, the joint probability for all observed
responses is a product of P(Zk = 0), P(Zk = 1, Zk1 = 0, Zk2 = 0), P(Zk = 1, Zk1 =
1, Yk1 = yk1, Zk2 = 0), P(Zk = 1, Zk1 = 0, Zk2 = 1, Yk2 = yk2), and P(Zk = 1, Zk1 =
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1, Yk1 = yk1, Zk2 = 1, Yk2 = yk2). Each of the above probabilities can be written as

ik , as shown in Appendix B. We can
a function of the individual probabilities p
then maximize the log-likelihood to obtain the MLE.
We have verified that for the same data set, the direct maximization of the
log-likelihood gives practically the same estimates to those given by the EM
algorithm (any differences are due to the convergence criteria). However, we still
prefer to use the EM algorithm to estimate parameters. This is because the loglikelihood (especially for halving) is a very complicated function of . When the
number of predictors in the model is large, the Newton-Raphson procedure can
be very slow. Also, the log-likelihood for array testing protocols does not have a
closed form solution, and consequently the EM algorithm is necessary for array
testing protocols.
We performed a small simulation study to examine the asymptotic distribution
of a LRT statistic. In our study, we simulate 1000 data sets, where each contains
5000 individual responses generated with an overall prevalence p. The covariates
are simulated from a Gamma(17, 1.4) distribution and the group responses are
formed with group size of I. Group, subgroup, and individual test responses for
Dorfman and halving are simulated using  and  as Bernoulli success
probabilities.

For

each

data

set,

we

fit

the

group

testing

model

logit(pik )  0  1xik to the responses, and calculate the LRT statistic for testing
H0: 1 = 0. A Kolmogorov-Smirnov test is performed on the simulated test
statistic values to determine if they follow a χ2(1) distribution. The results
showed that for different combinations of I, ,  and p, the χ2(1) approximation
works well for Dorfman and halving.
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4.3 ES Algorithm when Retesting Information is Available
When retests of individuals or groups of individuals are performed for a group
testing protocol, we can incorporate the retest results into the estimation process
for the ES algorithm developed in Chapter 3. Similar to our work in Section 2.2
for single-disease models, we can reformulate the conditional expectations in
Section 3.3.1 by taking into account the specific group testing protocol used.
When it is not possible to obtain a closed-form expression for these conditional
expectations, one can use Gibbs sampling, as demonstrated in Section 2.2.4, to
approximate them.
The expressions for the conditional expectations ijk can be easily found for
each group testing protocol by adding the extra subscript j to each term in the
expressions derived in Section 2.2. We demonstrate this here for Dorfman’s
protocol. If a group tests positive for disease j (Zjk = 1), then all individuals
within it will be individually retested. Denote these binary retest outcomes as
Yijk. We need to find the conditional means of the true individual responses given
the group responses. For observed negative groups where Zjk = 0 so that no
retests

are

performed,

the

conditional

mean

is

E (Yijk | Z jk  0)  (1  j )pijk / (1  jk ) . For observed positive groups where Zjk = 1,
the conditional mean ijk can be expressed as
ijk  P (Yijk  1 | Y1 jk  y1 jk ,...,YIk jk  yIk jk , Z jk  1)
 1 (y )

(1)
pijk j ijk
   i jkijk P (Yi jk  yi jk )
i i yi jk 0

.

Ik
Ik
1
(yi jk )
(0)

j  i jk (1  pi jk )  j   i jk P (Yi jk  yi jk )
i 1

i 1 yi jk 0

(y )
where ijkijk  P (Yijk  yijk | Yijk  yijk ) and j  1  j  j .
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With potentially multiple responses for each group (e.g., group responses Zjk
and individual retests Yijk), it is not clear what residuals represent from a model’s
fit. This is important because the residuals are needed to estimate the individual
correlations used in the ES Algorithm. If residuals based on the individual retests
are available, we can derive a similar relationship to Equation (12) between
Corr (Yijk ,Yij k ) and Corr (Yijk ,Yij k ) . However, some groups do not have any

retesting. Also, individual retests are not always performed for all diseases being
tested for a group, so we may not have both Yijk and Yij k for j  j . Thus, it is
usually not possible to estimate Corr (Yijk ,Yij k ) by including the retesting
information. As a result, we generally can use only the initial group responses to
estimate the correlation between diseases statuses. The estimation process is then
the same as described in Section 3.3.

4.4 Group Testing Model with Random Effects for Multiple-Disease
Data
The inclusion of random effects within a model is a standard technique used to
account for within-subject correlations in situations such as longitudinal data
analysis. In group testing contexts, Chen et al. (2009) is the only paper that has
incorporated random effects into a group testing regression model, and this
research was for the single-disease setting only. This sub-section proposals two
ways to estimate a model that includes a random effect to account for the within
subject correlation that occurs when multiple disease responses are observed.
Thus, this model could serve as an alternative to the methods described in
Chapter 3. Note the proposals given here have not been implemented due to
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expected computational difficulties. We present these two proposals as a record of
our research activities, and we hope that these proposals could serve as guidance
for future research in the area.
We continue to use the same notation as defined in Section 3.2. Regarding
each individual subject’s responses as a cluster, our model has the form:

logit(P (Yijk  1 | uik ))  Xik j  uik
′are
the covariates, j is a p×1 vector of fixed effects

where Xik = (x1ik, …, xp-1,ik)

parameters, and uik are i.i.d. ~ N(0, 2). We assume that each Yijk are
independent across the subjects i = 1, …, Ik within each group k, and we allow
for each Yijk to be independent for j = 1, …, J given uik. Note that Yijk are not
observed, and we use only the observable group responses Zjk to obtain parameter
estimates (no retests are performed). Within this setting, we can write the
probability of a group testing positive as
I

k
P (Z jk  1 | uk )  j  (1  j  j ) (1  P (Yijk  1 | uik ))

i 1

1
 j  (1  j  j )
.
i 1 1  exp(Xik j  uik )
Ik

Let Zk = (Z1k, Z2k, …, ZJk) denote a random vector of the trait responses for
group k = 1, …, K. We can concatenate these vectors as Z  (Z1, Z2, , ZK )
to form a vector of all group responses. We can write the joint density for Z as
f (z )  kK1 f (zk ) where f(×) denotes a probability distribution function. Note the

equality above is due to the independence of Z1, Z2, …, ZK (responses are
independent across groups). The joint density function for Zk is

f (zk )   f (zk , uk )duk   f (zk | uk )f (uk )duk ,
Ik

Ik
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where uk  (u1k , u2k , , uIk k ) is the vector of random effects for all individuals
in group k. In the above equation, f (uk )  iIk 1 f (uik ) due to the independence of
random effects across individuals. To find f (zk | uk ) in the above equation, let
yjk  (y1 jk , ..., yIk jk ) so that we can write the joint density of the individual

responses as
J

Ik

f (y1k , ..., yJk | uk )    f (yijk | uik )
j 1 i 1

for each group k. We can express f (zk | uk ) then as

f (zk | uk )




y1k ,...,yJk

f (z

k

| uk , y1k ,..., yJk )f (y1k ,..., yJk | uk )

J Ik


  f (zk | uk , y1k ,..., yJk )    f (yijk | uik )

j 1 i 1
y1k ,...,yJk 

J Ik
 J

    f (z jk | yjk )    f (yijk | uik )

j 1 i 1
y1k ,...,yJk 
 j 1
I
k
 
 J 
     f (z jk | yjk ) f (yijk | uik )
 
i 1
y1k ,...,yJk 
 j 1 
I
J 
 
k
 
    f (z jk | yjk ) f (yijk | uik )
 
j 1 
i 1
yjk 
J
  f (z jk | uk ).



j 1

In

the

above

derivation,

we

make

use

of

the

assumption

that

f (zk | uk , y1k , ..., yJk )  f (zk | y1k , ..., yJk )  Jj 1 f (z jk | yjk ) . This assumption
follows due to constant sensitivity and specificity levels once the true individual
responses are known and the Litvak et al. (1994) discussion that the test
outcomes are conditionally independent given the true outcomes. Summarizing,
we obtain
f (zk )   f (zk | uk )f (uk )duk
Ik


J
  Ik
    f (z jk | uk )   f (uik ) duk .

 i 1
Ik  j 1
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The log likelihood function l (2 | z ) can be written as
K
K

l (2 | z )   log( f (zk ))   log  
Ik
k 1
k 1


J
  Ik

  f (z jk | uk )   f (uik ) duk 


 j 1
 i 1

(20)

where   (1, 2, , J ) is the vector of all fixed effects,
z


 jk
Ik
1

f (z jk | uk )  j  (1  j  j )
 

i 1 1  exp(Xik j  uik ) 

1z

 jk
Ik
1
1    (1     )
 ,
j
j
j

i 1 1  exp(Xik j  uik ) 


and

f (uik ) 

 u2 
exp  ik2  .
 2 
2
1

To maximize the log-likelihood function and find the corresponding maximum
likelihood estimates (MLEs), one could approximate the integral in Equation (20)
by using adaptive Gauss-Hermite quadrature (Pinheiro and Bates 1995). We
expect this method to work when the group size Ik is small, but it would become
computationally expensive when the group size gets large. This is because the
likelihood function l (2 | z ) involves K different Ik dimensional integrals.
Therefore, when the group size Ik is large, evaluating the likelihood function
directly may be difficult or even intractable.
An alternative way to find maximize the likelihood function and find the
corresponding MLEs is through a modified version of the Monte Carlo expected
maximization (MCEM) algorithm described in Chen et al. (2009). First, the
complete joint log-likelihood function can be expressed as
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l (2 | z, u )  log( f (z | u )f (u ))
 log f (z | u )  log f (u )
K

J

Ik

K

   log f (z jk | uk )    log f (uik )
k 1 j 1

k 1 i 1

uik2
]
k 1 j 1
k 1 i 1
22

K J
K Ik u 2 
   log f (z jk | uk )  N log( 2)    ik2 ,

k 1 j 1
k 1 i 1 2 

K

J

Ik

K

   log f (z jk | uk )    [log( 2) 

where N   kK1 I k is the total number of individuals and we treat uik as missing.
To simplify the notation, define
K

J

I1    log f (z jk | uk ; )
k 1 j 1

uik2
,
2
k 1 i 1 2
K

Ik

I 2  N log( 2)   

where we include  in f (z jk | uk ; ) now to emphasize the fixed effect only
appears in I1. Also, notice that the variance component  appears only in I2.
Therefore, we can maximize both parts separately in the M-step to obtain ̂ and

̂2 . Given an initial estimate of the parameters, say, ((b ), (b ) ) , we could use the
Metropolis-Hastings algorithm to estimate E(I1|z) and E(I2|z) in the E-step
because f (uk | zk ; (b ), (b ) ) can not be expressed in a closed form. The algorithm
generates a large number of samples from f (uk | zk ; (b ), (b ) ) , and then use the
sample means to estimate E(I1|z) and E(I2|z). The MCEM algorithm is formally
given here:
1) Choose starting values (0), (0) of   .
2) (E-step). For a given (b ), (b ) , b = 0, 1, 2, …, approximate E(I1|z) and
E(I2|z) by
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1 M K J
(m )
Iˆ1(b ) 
   log f (z jk , uk , )
M m 1 k 1 j 1
1 M K Ik (uik(m ) )2
Iˆ2(b )  N log( 2) 
,
 
M m 1 k 1 i 1 22
respectively, where uk(m ) , m = 1, …, M, are M draws from the conditional
distribution f (uk | zk ; (b ), (b ) ) , k = 1, …, K, using the Metropolis-Hastings
algorithm.
3) (M-step). Update the parameter estimates to the (b + 1)th iteration by
maximizing Iˆ1(b ) with respect to  and maximizing Iˆ2(b ) with respect to s.
4) Repeat steps 2 and 3 until (b 1)  (b ) and (b 1)  (b ) are very small.
As Chen et al. (2009) pointed out, the MCEM algorithm is computationally
intensive, but is more flexible and can allow for other random effect distributions
and different pooling strategies.

4.5 GEE-group Approach for Multiple-Disease Data
The purpose of this sub-section is to illustrate how to formulate generalized
estimating equations in terms of the observed group responses so that standard
GEE methodology can be adapted to group testing problems. This would be
analogous to the approach taken by Vansteelandt et al. (2000) for single-disease
group testing models, and is an alternative to the ES algorithm fitting approach
to account for the correlation among disease responses.
To account for the correlation among different traits within each group, let
R() be the working correlation for Zk = (Z1k, Z2k, …, ZJk), where the matrix
depends on a vector of parameters . The working covariance matrix of Zk is
then Vk  Bk1/2R()Bk1/2 , where Bk is a J × J diagonal matrix with diagonal
elements jk(1  jk). The GEE for the multiple-disease group testing model is
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K

1
 DkVk (zk  k )  0 ,

(21)

k 1

where Dk  k /  , k = (1k, …, Jk), and 0 is a pJ × 1 vector of 0’s. Equation
(21) differs from the GEE as defined in Liang and Zeger (1986) by only the form
of Dk, which is more complicated now due to the relationship between jk and pijk
given in Equation (8).
To solve the estimating equations in (21) for , we need to estimate  first.
The

Pearson

residuals

of

the

group

responses

are

given

as

rˆjk  (z jk  ˆjk ) / ˆjk (1  ˆjk ), where ˆjk is the model’s estimate of jk. We can
calculate ̂ using these Pearson residuals in the moment estimators proposed by
Liang and Zeger (1986). For example, assuming the exchangeable correlation
structure where Corr (Z jk , Z j k )   for all j  j  , we have

 J (J  1)


K  Jp  .


2



K

ˆ    rˆjk rˆj k

k 1 j  j 

Parameter estimation and large sample normality of the estimators follow from
Liang and Zeger (1986). Parameter estimates can be found by iterating between a
modified Fisher scoring algorithm for  and estimating  based on the current
estimates of . Large sample properties then follow with ̂ having a large sample
normal distribution with mean  and covariance matrix



K

1
 DV
k k Dk

k 1


1

K

1
1
 DV
k k Cov(Zk )Vk Dk

k 1



K

1
 DV
k k Dk

k 1



1

.

Replacing  with ̂ ,  with ̂ , and Cov(Zk) with (zk  ˆk )(zk  ˆk ) in the above

ˆ.
formula gives us the estimated covariance matrix of 
Table 4.1 provides the GEE-group simulation results corresponding to the first
set of simulations given in Section 3.4. The GEE-group and ES algorithm do
provide similar results, despite the potential problems with the GEE-group
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approach outlined in Section 3.6. To further explore these potential problems, we
calculated Corr(Z1k, Z2k) for each group using Theorem 1 and a select subset of
our simulations. From Figure 4.1, we see that the correlation between Z1k and Z2k
varies somewhat over the groups; however, it appears that this variation is not
large enough to have a substantial effect on performance of the GEE-group
method.
We find it interesting that the GEE-group method can attain similar results as
the approach using the ES algorithm. This could occur because of the well-known
robustness properties of GEE in general. This finding does not void the merit of
our ES algorithm approach because 1) the ES algorithm allows one to specify a
working correlation structure on the individual scale, and 2) a direct
generalization of the ES algorithm that allows one to incorporate retesting
information, as described in Section 4.3, is possible. It is also worth noting that
our ES algorithm formulation for group testing data may be applicable in other
contexts involving latent correlated binary response data.

4.6 Future Research for Group Testing Regression Models
Section 4.2 provides the likelihood function for the Dorfman and halving protocol,
and preliminary simulation results suggest that the likelihood ratio tests for the
model parameters follow a chi-square distribution with degree of freedom 1. With
the likelihood function available, the residual deviance can be easily obtained, but
the degree of freedom associated with it is unknown because each individual is
observed multiple times (in a group and by itself) with these protocols. If the
degrees of freedom for the residual deviance can be determined, the deviance can
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serve as a goodness-of-fit (GOF) statistic for the model. Further, it would be
interesting to investigate how to generalize the GOF tests proposed by Chen et al
(2009) to incorporate retest results from Dorfman, halving, and other group
testing protocols. We expect that the test statistics for the GOF tests in Chen et
al (2009) could be modified accordingly. However, because the observed responses
will no longer be independent from each other, the asymptotic distributions of
the test statistics could be challenging to obtain.
In addition to Wald tests and likelihood ratio tests, score tests may also be
developed for group testing regression models. The EM algorithm theory implies
that (e.g., see Heyde and Morton (1996))
 log L(; y )
E


  log L(; x )






y  ,


(22)

where x denotes the complete data, y denotes the observed incomplete data, L is
the likelihood function based on either x or y. Note that the right hand side of
Equation (22) is the conditional score function, which is easily obtainable from
the

M-step

of

the

EM

algorithm.

The

Louis’s

(1982)

method

gives

E [2 log L(; y ) / 2 ] . As a result, the score test can be easily constructed

from the EM algorithm, and it is a very natural way of testing the parameters for
single-disease group testing models. Moreover, it is readily applicable to group
testing protocols whose likelihood function can not be explicitly expressed (e.g.,
array testing). Future work should examine the finite-sample performance of
these tests and compare the score tests to Wald and likelihood ratio tests.
Delaigle and Meister (2011) and Delaigle and Hall (2012) proposed a local
polynomial regression model for group testing data. They mainly illustrated their
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method with a single-covariate model. In the last section, the authors briefly
discussed how the kernel-based estimator can be generalized to the multivariate
setting. However, in a standard regression context, local regression models are
often less useful in higher dimensions (>2), unless we are willing to make simple
structure assumptions (e.g., additive models). This is because multidimensional
kernel estimators often require burdensome computations. We believe this is also
the case for group testing data. In group testing applications, there are often
many potential covariates for each individual subject, so the use of their method
is somewhat limited in practice. On the other hand, regression splines can be
easily extended to non-additive models. In particular, multivariate adaptive
regression splines (MARS) is a popular non-parametric regression technique for
modeling of high dimensional data. In the future, it would be of great practical
interest to investigate how to apply MARS to the group testing setting.
We have also briefly explored a Bayesian approach for group testing regression
models. The advantage of the Bayesian approach is that due to the use of
Markov Chain Monte Carlo (MCMC) methods, no complex algorithm is needed
for parameter estimation as long as enough MCMC samples are generated and
the model is correctly specified. This approach can be implemented directly in
standard statistical software (e.g., WinBUGS, R2WinBUGS package in R). For
example, we consider the following model for multiple-disease data (notation
follow from Section 4.4):
logit(P (Yijk  1 | uijk ))  Xik j  uijk ,

where
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I

k
P (Z jk  1 | uk )  j  (1  j  j ) (1  P (Yijk  1 | uijk ))

i 1

1
 j  (1  j  j )
,
i 1 1  exp(Xik j  uijk )
Ik

uik  (ui 1k ,..., uiJk ) , and uik i.i.d. ~ NJ (0, ) , for i = 1, …, Ik, k = 1, …, K. The
model here is a little different from the one in Section 4.4. More parameters are
introduced to allow for a more flexible correlation structure of the disease
statuses.

We

could

use

non-informative

priors

on

the

parameters:

j iid ~ N p (0,1000I j ) for j = 1, …, J, and 1 ~ WJ (2, I 2 ) where W is the

Wishart distribution. A simple simulated data set was fit by the above model in
WinBUGS, and estimated posterior densities for j and  were obtained. As
mentioned earlier, the Bayesian approach does not require a complex algorithm
for parameter estimation, and thus is highly flexible and suited for group testing
regression models. We believe it is worthwhile to explore this approach
extensively for various group testing protocols in the future.

82

Table 4.1. GEE-group simulation results corresponding to the model in Equation
(16) and to the simulations in Table 3.1. The true parameters are 01 = -6, 11 =
0, 02 = -7, 12 = 1, and 2 = 0.1. Estimated coverage is given for 95% Wald
confidence intervals.
 = 0.6, I = 5, K = 1000
01
Mean

02

11

12

2

 = 0.6, I = 10, K = 500
01

11

12

2

-5.98 -7.01 -0.03 0.99 0.10

-6.13 -7.20

0.00

1.08 0.10

SE/SD

0.96

0.96

0.99

0.95 0.94

0.99 0.96

0.93

0.91 0.94

Coverage

0.95

0.94

0.96

0.94 0.94

0.95 0.94

0.95

0.95 0.94
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01
Mean

02
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2
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01
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11
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2
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1.02 0.10
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0.02
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SE/SD

0.95
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0.94
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0.97 0.97

0.95

0.95 0.98

Coverage
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0.95

0.95 0.94

0.94 0.94

0.95

0.95 0.95
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01
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02

11

12

2
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01
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0.99

0.99

0.97

0.98 1.00

0.99 0.99

0.95

0.96 0.99
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Figure 4.1. True correlation between disease responses plotted over the groups.
The left-side plot is for the first generated data set from the  = 0.6, I = 5, and
K = 1000 simulations. The right-side plot is for the first generated data set from
the  = 0.6, I = 10, and K = 1000 simulations. The horizontal line is the
estimated working correlation found for that data set by using the GEE-group
method. Note that other simulated data sets gave very similar results.
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Appendix A
This appendix shows how to find ik for Dorfman’s protocol when Zk = 1. We
first express the conditional mean ik as
P (Yik  1 | Y1k  y1k ,...,YIk k  yIk k , Zk  1)
P (Yik  1,Y1k  y1k ,...,YIk k  yIk k , Zk  1)

P (Y1k  y1k ,...,YIk k  yIk k , Zk  1)
 P (Yik  1,Yi,k  yi,k ,Y1k  y1k ,...,YIk k  yIk k , Zk  1)
yi ,k

,
 P (Yk  yk ,Y1k  y1k ,...,YIk k  yIk k , Zk  1)

(23)

yk

k but without Y .
where Yk  (Y1k , ..., YI k ) and Yi,k is the same as Y
i ,k
k

Examining the numerator in (23) before the summation symbol, we have
P (Yik  1,Yi,k  yi,k ,Y1k  y1k ,...,YIk k  yIk k , Zk  1)
 P (Y1k  y1k ,...,YIk k  yIk k , Zk  1 | Yik  1,Yi,k  yi,k )P (Yik  1)P (Yi,k  yi,k )
 pik P (Yik  yik | Yik  1)P (Zk  1 | Yik  1,Yi,k  yi,k ) 
 P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
i i

  pik P (Yik  yik | Yik  1)  P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ),

(24)

i i

where we use the standard assumption that test outcomes are conditionally
independent given the true outcomes (Litvak et al. 1994). Similarly, from the
denominator of (23), we have

P (Yk  yk ,Y1k  y1k ,...,YIk k  yIk k , Zk  1)
 P (Y1k  y1k ,...,YIk k  yIk k , Zk  1 | Yk  yk )P (Yk  yk )
Ik

 P (Zk  1 | Yk  yk )  P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ).

(25)

i 1

Substituting (24) and (25) into (23) results in
 pik P (Yik  yik | Yik  1)   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
wik 

yi ,k i i
I

k
 P (Zk  1 | Yk  yk )  P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )

yk

i 1

.

(26)
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Equation (26) is very difficult to compute for large group sizes, because the
number of summands within it increases exponentially as the group size increases
I

(e.g., there are 2 k terms to sum in the denominator for group k). Fortunately,
we can reformulate the numerator and denominator to make Equation (26)
computationally feasible for large group sizes. The denominator can be written as
Ik

 P (Zk  1 | Yk  yk )  P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
i 1
Ik

yk

 P (Zk  1 | Zk  0)  P (Yi k  yi k | Yi k  0)(1  pi k ) 
i 1

I

k
P (Zk  1 | Zk  1)   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )

Ik

yk 0 i 1

 (1  )  P (Yi k  yi k | Yi k  0)(1  pi k ) 
i 1

 Ik 1

    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
i 1 yik 0

I
 k

   P (Yi k  yi k | Yi k  0)(1  pi k )
i 1

Ik

1

    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 
i 1 yi k 0
Ik

  P (Yi k  yi k | Yi k  0)(1  pi k ),
i 1

where  = 1 −  −  and we make use of the relation
I

k
  P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )

yk i 1
Ik

1

   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ).
i 1 yi k 0

Using the same technique, the numerator of (26) can be re-written in a similar
manner leading to
1

wik 

 pik P (Yik  yik | Yik  1)   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
i i yi k 0


  P (Yi k  yi k | Yi k  0)(1  pi k ) 
 i 1
Ik

Ik
1

   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )

i 1 yi k 0

. (27)
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The denominator (numerator) of Equation (27) is the product of Ik (Ik – 1) terms,
rather than the sum of 2Ik terms. Therefore, this formula makes finding ik
possible even for large group sizes.
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Appendix B
This appendix is a web appendix for the Chapter 2 paper submission. We show
here how to find ik for scenarios 1) to 5) of the halving protocol. The derivation
is very similar to that of Dorfman’s protocol.

1) Zk = 0:
This is the same as given in Section 2.2 for Dorfman’s protocol.

2) Zk = 1, Zk1 = 0, Zk2 = 0:
We need to find

P (Zk  1, Zk 1  0, Zk 2  0,Yik  1)
ik  P (Yik  1 | Zk  1, Zk 1  0, Zk 2  0) 
.
P (Zk  1, Zk 1  0, Zk 2  0)
For the denominator, we begin by including Yk  (Y1k , ..., YIk k )  (Yk1, Yk2 ) in the
expression to obtain
P (Zk  1, Zk 1  0, Zk 2  0)
  P (Zk  1, Zk 1  0, Zk 2  0 | Yk 1  yk 1,Yk 2  yk 2 )P (Yk 1  yk 1 )P (Yk 2  yk 2 )
yk

   P (Zk  1 | Yk 1  yk 1,Yk 2  yk 2 )P (Zk 1  0 | Yk 1  yk 1 )P (Yk 1  yk 1 )
yk 2 yk 1

P (Zk 2  0 | Yk 2  yk 2 )P (Yk 2  yk 2 )

Ik


 2 (1  )  (1  pi k )  (1  )  (1  pi k ) 1   (1  pi k ) 


i 1
i k 1
i k 2


(1  ) 1   (1  pi k )  (1  pi k )

 i k 2
i k 1



 (1  )2 1   (1  pi k ) 1   (1  pi k ) ,
i k 1
i k 2

 


where we let i  kj denote those individuals within the jth subgroup (j = 1, 2)
and we again use the standard assumption that test outcomes are conditionally
independent given the true outcomes (Litvak et al. 1994).
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Without loss of generality, we assume here and throughout this appendix that
individual i is within the first subgroup ( i  k 1 ). The numerator can be written
as

P (Yik  1, Zk  1, Zk 1  0, Zk 2  0)
  P (Zk  1, Zk 1  0, Zk 2  0 | Yik  1,Yi,k  yi,k )P (Yik  1,Yi,k  yi,k )
yi ,k

  (1  )P (Zk 2  0 | Yik  1,Yi,k  yi,k )P (Yi,k  yi,k )pik
yi ,k

 (1  )pik  P (Yi,k 1  yi,k 1 ) P (Zk 2  0 | Yk 2  yk 2 )P (Yk 2  yk 2 )
yi ,k 1

 (1  )pik  P (Zk 2
yk 2

yk 2

 0 | Yk 2  yk 2 )P (Yk 2  yk 2 )







 (1  )pik   (1  pi k )  (1  ) 1   (1  pi k ) ,


i k 2
i k 2
where Yi,k  {Yi ,k : i   1,..., I k , i   i} is the vector of all true individual statuses
excluding the ith subject in group k and Yi,k 1  {Yi ,k 1 : i   k 1, i   i} is the vector
of all true individual statuses excluding the ith subject in subgroup k1.

3) Zk = 1, Zk1 = 1, Zk2 = 0:
We need to find

ik  P (Yik  1 | Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0)
P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0,Yik  1)

.
P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0)
Using the same technique as above, we calculate the denominator to be
P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0)
  P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0 | Yk 1  yk 1,Yk 2  yk 2 ) 
yk

P (Yk 1  yk 1 )P (Yk 2  yk 2 )
   P (Zk  1 | Yk 1  yk 1,Yk 2  yk 2 )P (Zk 1  1 | Yk 1  yk 1 ) 
yk 2 yk 1

 P (Yi k  yi k | Yi k  yi k )P (Yk 1  yk 1 )P (Zk 2  0 | Yk 2  yk 2 )P (Yk 2  yk 2 )

i k 1
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 (1  )2  P (Yi k  yi k | Yi k  0)(1  pi k )  (1  pi k ) 
i k 1

i k 2



(1  )(1  )  P (Yi k  yi k | Yi k  0)(1  pi k ) 1   (1  pi k ) 


i k 1
i k 2


2    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )  (1  pi k ) 
i k 2
yk 1 0 i k 1



2 (1  )    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 1   (1  pi k ) .
 

i k 2
yk 1 0 i k 1
The numerator can be expressed as
P (Yik  1, Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0)
  P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  0 | Yik  1,Yi,k  yi,k ) 
yi ,k

P (Yik  1,Yi,k  yi,k )
  2P (Yik  yik | Yik  1)  P (Yi k  yi k | Yi k  yi k ) 
yi ,k

i k 1,i i

P (Zk 2  0 | Yk 2  yk 2 )P (Yi,k  yi,k )pik
 2 pik P (Yik  yik | Yik  1) 


   P (Yi k  yi k | Yi k  yi k )P (Zk 2  0 | Yk 2  yk 2 )P (Yi,k  yi,k )

yi ,k i k 1,i i


 2 pik P (Yik  yik | Yik  1)    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 

yi ,k 1 i k 1,i i


 P (Zk 2  0 | Yk 2  yk 2 )P (Yk 2  yk 2 )
yk 2



 2 pik P (Yik  yik | Yik  1)    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 

yi ,k 1 i k 1,i i


  (1  pi k )  (1  ) 1   (1  pi k ) .


i k 2
i k 2





4) Zk = 1, Zk1 = 0, Zk2 = 1:
We need to find

ik  P (Yik  1 | Zk  1, Zk 1  0, Zk 2  1,Yk 2  yk 2 )
P (Zk  1, Zk 1  0, Zk 2  1,Yk 2  yk 2 ,Yik  1)
.

P (Zk  1, Zk 1  0, Zk 2  1,Yk 2  yk 2 )
The denominator follows immediately from previous result by interchanging k1
and k2:
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P (Zk  1, Zk 1  0, Zk 2  1,Yk 2  yk 2 )
 (1  )2  P (Yi k  yi k | Yi k  0)(1  pi k )  (1  pi k ) 
i k 2

i k 1



(1  )(1  )  P (Yi k  yi k | Yi k  0)(1  pi k ) 1   (1  pi k ) 
i k 2
i k 1




2
    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )  (1  pi k ) 
i k 1
yk 2 0 i k 2



2
 (1  )    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 1   (1  pi k ) .
 
i k 1
yk 2 0 i k 2

We can show the numerator has the following form:
P (Yik  1, Zk  1, Zk 1  0, Zk 2  1,Yk 2  yk 2 )
  P (Zk  1, Zk 1  0, Zk 2  1,Yk 2  yk 2 | Yik  1,Yi,k  yi,k ) 
yi ,k

P (Yik  1,Yi,k  yi,k )
  (1  )  P (Yi k  yi k | Yi k  yi k )P (Zk 2  1 | Yk 2  yk 2 )P (Yi,k  yi,k )pik
yi ,k

i k 2

 (1  )pik 


   P (Yi k  yi k | Yi k  yi k )P (Zk 2  1 | Yk 2  yk 2 )P (Yi,k  yi,k )

yi ,k i k 2


 (1  )pik  P (Yi,k 1  yi,k 1 ) 
yi ,k 1



   P (Yi k  yi k | Yi k  yi k )P (Zk 2  1 | Yk 2  yk 2 )P (Yk 2  yk 2 )

yk 2 i k 2

 1

 (1  )pik       P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 
 i k 2 yik 0


  P (Yi k  yi k | Yi k  0)(1  pi k ) ,

i k 2

where  = 1 −  − .

5) Zk = 1, Zk1 = 1, Zk2 = 1:
We need to find

ik  P (Yik  1 | Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 )
P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 ,Yik  1)

.
P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 )
The denominator can be written as:
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P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 )
  P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 | Yk  yk )P (Yk  yk )
yk

  P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 | Yk 1  yk 1,Yk 2  yk 2 ) 
yk

P (Yk 1  yk 1 )P (Yk 2  yk 2 )
   P (Zk  1 | Yk 1  yk 1,Yk 2  yk 2 )P (Zk 1  1 | Yk 1  yk 1 )
yk 2 yk 1

P (Zk 2  1 | Yk 2  yk 2 )  P (Yi k  yi k | Yi k  yi k )  P (Yi k  yi k | Yi k  yi k )
i k 1

P (Yk 1  yk 1 )P (Yk 2  yk 2 )

i k 2

I

k
 (1  )3  P (Yi k  yi k | Yi k  0)(1  pi k ) 

i 1

 (1  )  P (Yi k  yi k | Yi k  0)(1  pi k ) 
2

i k 1



   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 


yk 2 0 i k 2


2 (1  )    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 


yk 1 0 i k 1

 P (Yi k  yi k | Yi k  0)(1  pi k ) 
i k 2



 3    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 

yk 1 0 i k 1


   P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ),

yk 2 0 i k 2
and the numerator can be expressed as:

P (Yik  1, Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 )
  P (Zk  1, Zk 1  1,Yk 1  yk 1, Zk 2  1,Yk 2  yk 2 | Yik  1,Yi,k  yi,k ) 
yi ,k

P (Yik  1,Yi,k  yi,k )
  2P (Yik  yik | Yik  1)  P (Yi k  yi k | Yi k  yi k ) 
yi ,k

i k 1,i i

 P (Yi k  yi k | Yi k  yi k )P (Zk 2  1 | Yk 2  yk 2 )P (Yi,k  yi,k )pik
i k 2
 2 pik P (Yik  yik | Yik  1) 

   P (Yi k  yi k | Yi k  yi k )  P (Yi k  yi k | Yi k  yi k ) 
i k 2
yi ,k i k 1,i i


P (Zk 2  1 | Yk 2  yk 2 )P (Yi,k  yi,k )


 2 pik P (Yik  yik | Yik  1)    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 

yi ,k 1 i k 1,i i


   P (Yi k  yi k | Yi k  yi k )P (Zk 2  1 | Yk 2  yk 2 )P (Yk 2  yk 2 )


i k 2
y
k2
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 2 pik P (Yik  yik | Yik  1)    P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k ) 

yi ,k 1 i k 1,i i

 1

     P (Yi k  yi k | Yi k  yi k )P (Yi k  yi k )
 i k 2 yik 0


   P (Yi k  yi k | Yi k  0)(1  pi k ) .

i k 2
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Appendix C
This appendix includes the derivations of the expression for ij for the array
testing protocol. We can write ij as
P (Yij  1 | Yi, j  yi, j , R  r ,C  c,YQ = yQ )
P (Yij  1,Yi, j  yi, j , R  r,C  c,YQ = yQ )

.
P (Yi, j  yi, j , R  r,C  c,YQ = yQ )

(28)

First, to find the numerator of Equation (28), we have
P (Yij  yij ,Yi, j  yi, j , R  r ,C  c,YQ = yQ )
 P (R  r ,C  c,YQ = yQ | Yij  yij ,Yi, j  yi, j )P (Yij  yij )P (Yi, j  yi, j )
 P (R  r ,C  c | Yij  yij ,Yi, j  yi, j ,YQ = yQ ) 
P (YQ = yQ | Yij  yij ,Yi, j  yi, j )P (Yij  yij )P (Yi, j  yi, j )
 P (R  r | Yij  yij ,Yi, j  yi, j )P (C  c | Yij  yij ,Yi, j  yi, j ) 
I

J

  P (Yst  yst | Yst  yst )  pijyij (1  pij )1yij   pyij (1  pi j  )1yij  ,
ij
(s ,t )Q

i 1 j 1


{i i , j  j }

where we use the same conditional assumptions as in Appendix A and
I

J

y

1yi j 

  pi ijj (1  pi j  )

i 1 j 1
{i i , j  j }

denotes the product is taken over all combinations of i = 1,…, I and j = 1, …, J
except the (i, j) combination. Then
P (Yij  yij ,Yi, j  yi, j , R  r ,C  c,YQ = yQ )

I
 J

   P (Ri  ri | Yi 1  yi 1, ,YiJ  yiJ )   P (C j  cj | Y1 j  y1 j , ,YIj  yIj )
  j 1

i 1
(29)
I J


1y
y
   P (Yst  yst | Yst  yst )    pijij (1  pij ) ij 

(s ,t )Q
 i 1 j 1
due to the independence among row responses and among column responses.
Define
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 I

    P (Ri   ri  | Yi 1  yi 1, ,Yi J  yi J ) 
i 1

i i

J

  I J y
1y 
  P (C j   cj  | Y1 j   y1 j  , ,YIj   yIj  )    pi ijj (1  pi j  ) ij  
 j 1
 i 1 j 1

 j  j
 {i i, j  j }


for notational simplicity. Noting that Yij  1 is in the numerator of Equation
(28) and if (i, j)  Q, we find that Equation (29) becomes
P (Yij  1,Yi, j  yi, j , R  r ,C  c,YQ = yQ )
i  1)P (C j  cj | Cj  1) 
P (Yst  yst | Yst  yst ) P (Ri  ri | R
  

(s ,t )Q \{(i, j )}

P (Yij  yij | Yij  1)pij ,

where (s, t )  Q \ {(i, j )} means all indices in Q except for (i, j) and Ri and Cj are
the true values for Ri and Cj, respectively. When (i, j)  Q, Equation (29)
becomes
P (Yij  1,Yi, j  yi, j , R  r,C  c,YQ = yQ )
i  1)P (C j  cj | Cj  1)pij .
    P (Yst  yst | Yst  yst ) P (Ri  ri | R

s
t
Q
(
,
)



The above equation helps to show the contributions that the individual retests
have on the probabilities. Simply, for large sensitivities and specificities, they
contribute values close to 0 or 1.
Second, to find the denominator of Equation (28), note that
P (Yi, j  yi, j , R  r,C  c,YQ = yQ )
 P (Yij  0,Yi, j  yi, j , R  r,C  c,YQ = yQ ) 
P (Yij  1,Yi, j  yi, j , R  r,C  c,YQ = yQ ).

Using results from Equation (29), we can write the probability for (i, j)  Q as

P (Yi, j  yi, j , R  r,C  c,YQ = yQ )
P (Yst  yst | Yst  yst ) 
  

(s ,t )Q \{(i, j )}




P(Ri  ri | Yi1  yi1, ,Yij  0, ,YiJ  yiJ ) 
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P (C j  cj | Y1 j  y1 j , ,Yij  0, ,YIj  yIj )P (Yij  yij | Yij  0)(1  pij ) 
i  1)P (C j  cj | Cj  1)P (Yij  yij | Yij  1) pij 
P (Ri  ri | R
and for (i, j)  Q:
P (Yi, j  yi, j , R  r,C  c,YQ  yQ )
   P (Yst  yst | Yst  yst ) P (Ri  ri | Yi 1  yi 1, ,Yij  0, ,YiJ  yiJ ) 
(s ,t )Q

P (C j  cj | Y1 j  y1 j , ,Yij  0, ,YIj  yIj )(1  pij ) 
i  1)P (C j  cj | Cj  1)pij  .
P (Ri  ri | R

Combining all the results, we have for (i, j)  Q:
ij 

i  1)P (C j  cj | Cj  1)P (Yij  yij | Yij  1)pij
P (Ri  ri | R
{P (Ri  ri | Yi 1  yi 1, ,Yij  0, ,YiJ  yiJ ) 
P (C j  cj | Y1 j  y1 j , ,Yij  0, ,YIj  yIj )P (Yij  yij | Yij  0)(1  pij ) 
i  1)P (C j  cj | Cj  1)P (Yij  yij | Yij  1)pij }
P (Ri  ri | R

and for (i, j)  Q:
ij 

i  1)P (C j  cj | Cj  1)pij
P (Ri  ri | R
.
{P (Ri  ri | Yi 1  yi 1, ,Yij  0, ,YiJ  yiJ ) 
P (C j  cj | Y1 j  y1 j , ,Yij  0, ,YIj  yIj )(1  pij ) 
i  1)P (C j  cj | Cj  1)pij }
P (Ri  ri | R

Note that for the case of no individual retests, the formula for (i, j )  Q should be
used for all i and j.
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Appendix D
This appendix is a web appendix for the Chapter 2 paper submission. We show
here a histogram of the true individual probabilities for one simulated data set in
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p
ik

Figure D.1. Histogram of the true individual probabilities for one simulated data
set in Section 2.3.
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Appendix E
This appendix is a web appendix for the Chapter 2 paper submission. Below are
the average number of tests performed by each protocol for 500 simulated data
sets, each containing 5000 individuals, with  =  = 0.99 in Section 2.3.2.

Table E.1. Average number of tests performed by each protocol for 500 simulated
data sets in Section 2.3.2.

Array w/o

Array w/

Group Size

IG

Dorfman

Halving

retesting

retesting

4

1250

1522

1500

2502

2652

6

834

1214

1129

1669

1812

8

625

1111

968

1254

1398

10

500

1087

891

1000

1144

12

417

1107

857

837

993

14

358

1149

848

720

897

16

313

1196

844

633

831

18

278

1251

854

564

790

20

250

1321

875

510

771
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Appendix F
This appendix is a web appendix for the Chapter 2 paper submission. We discuss
here additional simulations used to reinforce the findings in Section 2.3. We
simulate

data

for

each

testing

protocol

according

to

the

model

logit(pik )  0  1xik ( logit(pij )  0  1xij for the array testing protocols), where
0 = -6 and 1 = 4.7. The covariates are generated from a Uniform(0, 1)
distribution. These configurations provide an overall mean prevalence of about
0.05. The sensitivity and specificity are set to be  =  = 0.99. Each simulated
data set contains 5000 individuals. The range of the group sizes included in this
study is reasonable given the prevalence level.
Figures F.1-F.3 give the results. Overall, we see that the results from Chapter
2 continue to hold true here. Note that  of IG begins to increase with the group
sizes in Figure F.3, which it did not for the simulations in Chapter 2. This occurs
due to the larger overall prevalence that leads to some of the larger group sizes
not being ideal for IG.
Note that Figure F.4 provides a histogram of the true individual probabilities
for one simulated data set under the simulation settings.
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Figure F.1. Estimated relative efficiencies calculated by Equation (6) based on
500 simulated data sets. Dorfman and halving are compared to IG. Array testing
is compared with and without retests.
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Figure F.2. Averaged Var (ˆ1 ) for 500 simulated data sets. The horizontal dashed
line corresponds to Var (ˆ1 ) from individual testing. The right-side plot is the
same as on the left-side except we omit IG in order to reduce the y-axis scale.
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Figure F.3. Average number of tests per unit of information calculated by
Equation (7) based on 500 simulated data sets. Note that  = 903 for individual
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Figure F.4. A histogram of the true individual probabilities for one simulated
data set.
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Appendix G
This appendix is a web appendix for the Chapter 3 paper submission. In this
appendix, we give the proof of Theorem 1 in Section 3.3.2. The covariance
between Z jk and Z j k is
Cov(Z jk , Z j k )  P (Z jk  1, Z j k  1)  P (Z jk  1)P (Z j k  1),

where
P (Z jk  1, Z j k  1)
   P (Z jk  1, Z j k  1 | Yjk  yjk ,Yj k  yj k )P (Yjk  yjk ,Yj k  yj k )
yj k yjk

   P (Z jk  1 | Yjk  yjk )P (Z j k  1 | Yj k  yj k )P (Yjk  yjk ,Yj k  yj k ) (30)
yj k yjk

and Yjk  (Y1 jk , ..., YIk jk ) . In Equation (30), we write the joint probability
P (Z jk  1, Z j k  1 | Yjk  yjk ,Yj k  yj k )

conditional

probabilities

as the product of the marginal

P (Z jk  1 | Yjk  yjk )

and

P (Z j k  1 | Yj k  yj k )

using a conditional independence assumption (see Litvak, Tu, and Pagano (1994)
for justification).
Categorizing with respect to the possible values of yjk and yj k , we split the
summation in Equation (30) into four parts. The first part corresponds to the
case where yjk and yj k are vectors of 0’s, which leads to

P (Z jk  1 | Yjk  yjk )P (Z j k  1 | Yj k  yj k )P (Yjk  yjk ,Yj k  yj k )
I

k
 (1  j )(1  j  ) P (Yijk  0,Yij k  0).

i 1

The second part corresponds to the case where yj k is a vector of 0’s and at least
one

yijk

for

1

≤

i

≤

Ik

is

not

Qj = {yjk | at least one yijk for 1  i  I k is not 0} , we obtain

0.

Defining

110
 P (Z jk  1, Z j k  1 | Yjk  yjk ,Yj k  0)P (Yjk  yjk ,Yj k  0)

yjk Qj

 j (1  j  )  P (Yjk  yjk ,Yj k  0).
yjk Qj

(31)

Because yjk Qj P (Yjk  yjk ,Yj k  0)  P (Yjk  0,Yj k  0)  P (Yj k  0), Equation (31)
can be further written as
Ik
 Ik

j (1  j  )   (1  pij k )   P (Yijk  0,Yij k  0) .
i 1

i 1

Similar to the second part, the third part of the summation in Equation (30)
corresponds to the case where at least one of yij k for 1  i  I k is not 0 while yjk
is a vector of 0’s. This results in

 P (Z jk  1, Z j k  1 | Yjk  0,Yj k  yj k )P (Yjk  0,Yj k  yj k )

yj k Qj 

Ik
 Ik



 j  (1  j )   (1  pijk )   P (Yijk  0,Yij k  0) .


i 1
i 1




Finally, the fourth part corresponds to the case where there is at least one
positive individual for both disease j and j′. We find that



 P (Z jk  1, Z j k  1 | Yjk  yjk ,Yj k  yj k )P (Yjk  yjk ,Yj k  yj k )

yjk Qj yj k Qj 

 j j  

 P (Yjk  yjk ,Yj k  yj k )

yjk Qj yj k Qj 


 j j  1  P (Yjk  0,Yj k  0)   P (Yjk  yjk ,Yj k  0)

yjk Qj

  P (Yjk  0,Yj k  yj k )

yj k Qj 
Ik
Ik

 Ik

 j j  1   P (Yijk  0,Yij k  0)    (1  pij k )   P (Yijk  0,Yij k  0)

i 1
i 1
i 1

Ik

 Ik

   (1  pijk )   P (Yijk  0,Yij k  0)
i 1
i 1

Ik
Ik
Ik


 j j  1   P (Yijk  0,Yij k  0)   (1  pijk )   (1  pij k ) .


i 1
i 1
i 1
Combining the above results, we have
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P (Z jk  1, Z j k  1)
I

k
 (1  j )(1  j  ) P (Yijk  0,Yij k  0)

i 1

Ik
 Ik



 j (1  j  )   (1  pij k )   P (Yijk  0,Yij k  0)


i 1
i 1



Ik
Ik




 j  (1  j )   (1  pijk )   P (Yijk  0,Yij k  0)


i 1
i 1



I
I
Ik
k
k




 j j  1   P (Yijk  0,Yij k  0)   (1  pijk )   (1  pij k ) .


i 1
i 1
i 1





Shifting focus to P (Z jk  1)P (Z j k  1) in Equation (30), we notice that

P (Z jk  1)   P (Z jk  1 | Yjk  yjk )P (Yjk  yjk )
yjk

Ik


 (1  j ) (1  pijk )  j 1   (1  pijk ) .


i 1
i 1
Ik

Thus,

P (Z jk  1)P (Z j k  1)
Ik
Ik



 (1  j ) (1  pijk )  j 1   (1  pijk ) 

 i 1

i 1
Ik
I

k


(1  j  ) (1  pij k )  j  1   (1  pij k )

 i 1

i 1
I
 k

 (1  j )(1  j  )   (1  pijk )(1  pij k )
i 1

Ik
 Ik

j (1  j  )   (1  pij k )   (1  pijk )(1  pij k )
i 1
i 1

Ik
 Ik

 j  (1  j )   (1  pijk )   (1  pijk )(1  pij k )
i 1

i 1
I
I
I
k
k
k


 j j  1   (1  pijk )   (1  pij k )   (1  pijk )(1  pij k ) .
 i 1

i 1
i 1
Subtracting P (Z jk  1)P (Z j k  1) from P (Z jk  1, Z j k  1) , the covariance
becomes
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Cov(Z jk , Z j k )
Ik
 Ik

 (1  j )(1  j  ) 
  P (Yijk  0,Yij k  0)   (1  pijk )(1  pij k )



i 1
i 1



I
I
k
k



 j (1  j  )   P (Yijk  0,Yij k  0)   (1  pijk )(1  pij k )


i 1
i 1



Ik
Ik




 j  (1  j )   P (Yijk  0,Yij k  0)   (1  pijk )(1  pij k )


i 1
i 1



I
I
k
k



 j j    P (Yijk  0,Yij k  0)   (1  pijk )(1  pij k )


i 1
i 1



Ik
Ik




 (j  j  1)(j   j   1)   P (Yijk  0,Yij k  0)   (1  pijk )(1  pij k ) .


i 1



i 1

P (Yijk  0,Yij k  0)  P (Yijk  0)P (Yij k  0)

Because

=

Cov(1 Yijk ,1 Yij k )

Cov(Yijk ,Yij k ), we can write

Cov(Z jk , Z j k )
 (j  j  1)(j   j   1) 
Ik
 Ik



  Cov(Yijk ,Yij k )  (1  pijk )(1  pij k )   (1  pijk )(1  pij k )


i 1
i 1



 (j  j  1)(j   j   1) 
 Ik
  Var (Yijk )Var (Yij k )Corr (Yijk ,Yij k )  (1  pijk )(1  pij k )
i 1
Ik

  (1  pijk )(1  pij k )

i 1



for 1  j, j′  J, j  j , and k = 1, …, K.



=
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Appendix H
This appendix is a web appendix for the Chapter 3 paper submission. The
purpose hereis to illustrate the existence of a unique solution ˆs and the
consistency of ̂ when  is known, as discussed in Section 3.3.2. For generality,
we examine an unspecified working correlation structure. More refined arguments
for specific correlation structures follow analogously.
For the same group, but different disease, Theorem 1 gives the covariance
between two group responses as

Cov(Z jk , Z j k )
 (j  j  1)(j   j   1) 
 Ik
  jj  pijk (1  pijk )pij k (1  pij k )  (1  pijk )(1  pij k )
i 1
Ik

 (1  pijk )(1  pij k ) ,

i 1





(32)

which is a function of Corr (Yijk ,Yij k )  jj  , for j  j  . It is obvious that this
function passes through the origin and has positive coefficients. Therefore,
Cov(Z jk , Z j k ) is an increasing function of jj  when jj   0 .

For 1  jj   0, notice that jj  pijk (1  pijk )pij k (1  pij k )  (1  pijk )(1  pij k ) is an
increasing function of jj  , for each i = 1, …, Ik. When pijk and pij k are less
than or equal to 0.5, we have
(1  pijk )(1  pij k )  jj  pijk (1  pijk )pij k (1  pij k )
 (1  pijk )(1  pij k )  pijk (1  pijk )pij k (1  pij k )
 (1  pijk )(1  pij k )
0



(1  pijk )(1  pij k )  pijk pij k
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Hence, jj  pijk (1  pijk )pij k (1  pij k )  (1  pijk )(1  pij k ) is non-negative in this
situation, and the product
Ik





 jj  pijk (1  pijk )pij k (1  pij k )  (1  pijk )(1  pij k )

i 1

is an increasing function of jj  , for 1  jj   0 . Thus, Cov(Z jk , Z j k ) is an
increasing function of jj  for jj   0 and also for 1  jj   0 when pijk and pij k
are less than or equal to 0.5. The right hand side of Equation (14) is the sum of
Cov(Z jk , Z j k ) terms over k = 1, …, K, and thus will also be monotonic increasing

in jj  . The existence of a unique solution in Equation (14) immediately follows.
When some pijk and pij k are greater than 0.5 and 1  jj   0 , Cov(Z jk , Z j k )
may not be monotone, which could lead to more than one solution in Equation
(14). However, this would be unlikely to occur for the following reasons: (a)
Disease statuses most likely will have a non-negative correlation, i.e., jj   0 , (b)
Most individual probabilities will be less than 0.5 in realistic settings; otherwise,
we would not use group testing, and (c) The estimate of jj  comes about
through solving Equation (14), where we sum over all groups rather than
examine only one group. Because most pijk and pij k are less than 0.5 within
groups, we postulate that the right hand side of (14) will still be a monotonic
function, which leads to a unique solution for jj  .
To prove the consistency of ̂ , we define
gk (jj  )  (Z jk  jk )(Z j k  j k )  (j  j  1)(j   j   1) 
 Ik
  jj  pijk (1  pijk )pij k (1  pij k )  (1  pijk )(1  pij k )
i 1
Ik

 (1  pijk )(1  pij k )

i 1
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for k = 1, …, K, j  j  , and gK   kK1 gk / K for a fully unspecified working
correlation structure. Due to the independence of group responses across groups,
each gk is independent of each other. Furthermore, clearly E(gk) = 0 from
Equation (32), so that E(gK) = 0 as well. It is obvious that Var (gk )   and

lim Var ( kK1 gk ) / K 2  lim  kK1Var (gk ) / K 2  .

K 

K 

By the Chebyshev law of large numbers (e.g., see Serfling (1980, p. 27)),

gK (jj  )  0 in probability. Similar to Liang and Zeger (1995, p. 163),
ˆjj   gK1(0)  jj  provided that gK is continuous and one-to-one. Thus ̂ is a
consistent estimator for  when  is known.

116

Appendix I
This appendix is a web appendix for the Chapter 3 paper submission. The
purpose here is to show how to derive the linear and quadratic coefficients in
Section 3.3.2 and explain why using the first and second order terms give close
estimates to the exact solution in Equation (14). To find the linear term in
Ik





 jj  pijk (1  pijk )pij k (1  pij k )  (1  pijk )(1  pij k ) ,

i 1

we choose a jj  pijk pij k (1  pijk )(1  pij k ) term and multiply it with the other Ik – 1
remaining (1  pijk )(1  pij k ) terms to obtain





)  (1  p

jj 

p1 jk p1 j k (1  p1 jk )(1  p1 j k )  (1  pijk )(1  pij k ) 

jj 

p2 jk p2 j k (1  p2 jk )(1  p2 j k

i 1

... 



jj 

i 2



ijk

)(1  pij k ) 

pIk jk pIk j k (1  pIk jk )(1  pIk j k )  (1  pijk )(1  pij k )
Ik

i Ik

 jj   pijk pij k (1  pijk )(1  pij k )  (1  pi jk )(1  pi j k )
i i

i 1



pijk pij k


.
 jj    (1  pijk )(1  pij k ) 


i 1
 i 1 (1  pijk )(1  pij k )


Ik

Ik

Similarly for the quadratic term, from the Ik products we pick two
jj  pijk pij k (1  pijk )(1  pij k ) terms and multiply them with the other Ik – 2

remaining (1  pijk )(1  pij k ) terms. The product can be written as

pi1 jk pi1 j k
pi2 jk pi2 j k
 Ik

jj2    (1  pijk )(1  pij k ) 
.
i 1
 1i1 i2 Ik (1  pi1 jk )(1  pi1 j k ) (1  pi2 jk )(1  pi2 j k )
We can obtain the coefficient of the lth order term as
l
pim jk pim j k
 Ik

ljj    (1  pijk )(1  pij k ) 

i 1
 1i1 ...il Ik m 1 (1  pim jk )(1  pim j k )
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for l = 1, …, Ik. Because the pijk are generally small for group testing
applications, we expect that lm 1 pim jk pim j k / {(1  pim jk )(1  pim j k )} becomes
extremely small rather quickly as l increases. For example, in the simplified case
of pijk  p , one can show that the ratio of the l th to the (l – 1)th term is
I k  p
 
 l  1  p jj 
 
I  l  1 p
jj  .
 k
 I k 

1
l
p



l  1



(33)

Because (I k  l  1) / l is a decreasing function of l, p is generally small, and
1  jj   1 , Equation (33) is close to 0 and decreases as l increases. For

example, if p = 0.03, Ik = 5, and jj  = 0.6, then the quadratic term is 3.7% of
the linear term and the cubic term is only 1.9% of the quadratic term.
To examine the approximation more closely, we performed the following
simulation study. Consider the model

logit(pijk )  0 j  1 j x1ik ,
where j = 1, 2 and Corr (Yi 1k ,Yi 2k )  . The covariate x1ik is generated from a
gamma(17, 1.4) distribution. The true parameters of the model are 01 = -7, 11
= 0.13, 02 = -6, and 12 = 0.1. We simulate 5 data sets and estimate  using
Equation (14) (we refer to this as “exact”) and using first- and second-order
approximations as outlined in Section 3.3.2. Table I.1 gives the estimates, and it
shows

that

the

second-order

approximating the exact result.

approximation

works

especially

well

at
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Table I.1. Comparison of  estimates averaged over 5 simulated data sets. The
average time in minutes that our R function took to estimate each model is
shown for a computer with a 2.2GHZ processor and 3GB of memory.

Exact


j

j

1

1

0.95

0.95

1

1

0.95

0.95

0.6

0.2

First-order

Second-order

K

I

a ̂ a

Time

a ̂ a

Time

a ̂ a

Time

1000

5

0.6262

1.25

0.6486

0.47

0.6264

0.70

500

10

0.6072

4.53

0.6551

0.47

0.6087

0.75

1000

5

0.5700

1.68

0.5899

0.65

0.5701

0.86

500

10

0.5684

4.76

0.6026

0.52

0.5695

0.85

1000

5

0.1715

1.20

0.1733

0.43

0.1715

0.69

500

10

0.1767

4.58

0.1807

0.51

0.1768

0.79

1000

5

0.2190

1.38

0.2217

0.57

0.2191

0.83

500

10

0.1835

4.88

0.1883

0.60

0.1836

0.91
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Appendix J
This appendix is a web appendix for the Chapter 3 paper submission.
1. Histograms of the true individual probabilities for one simulated data set
j=2

20

Density
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~
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Figure J.1. Histograms of the true individual probabilities for one Section 3.4
simulated data set using the model in Equation (16) with  = 0.6, K = 1000, and
Ik = 5.
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2. Simulation results from estimating 21 and 22 separately
Table J.1. Relative efficiency of the variance estimates for the model in Equation
(16). Note that each 21 and 22 is estimated separately by the ES algorithm.

logit(pˆ)

0.6
0.2

̂01

̂02

̂11

̂12

̂21

̂22

K

Ik

j=1 j=2

2000

5

1.053 1.039 1.054 1.038 1.041 1.047

1.093 1.015

1000 10

1.064 1.069 1.060 1.068 1.061 1.072

1.110 1.061

2000

5

1.016 1.025 1.014 1.027 1.014 1.025

1.011 1.011

1000 10

1.043 1.043 1.031 1.056 1.041 1.035

1.024 1.030
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3. Additional simulations
Additional simulations were performed to support the findings in Section 3.4 with
different models. We used the model logit(pijk )  0 j  1 j x1ik with 01 = -6.3, 02
= -6.6, 11 = 4.0, 12 = 4.7, where xik ~ uniform(0, 1) and j  j  1 for j = 1, 2.
These covariate and parameter configurations lead to a mean prevalence of
approximately 0.02 for disease j = 1 and 0.03 for disease j = 2. The results are
given in Table J.2, and they are very similar to Table J.1 for the two-covariate
model. Specifically, the ES algorithm leads to more efficient estimators than
those from separate models; also, further benefits are realized by estimating the
correlation between the disease responses. As would be expected, the benefits
from estimating the correlation decrease as a function of .

Table J.2. Relative efficiency of the variance estimates for logit(pijk )  0 j  1 j x1ik .
ˆ) is calculated at values of xik = 0.1, 0.2,
The relative efficiency involving logit(p

…, 0.9, and the maximum and minimum relative efficiencies are reported in the
table.
logit(pˆ)

0.8

0.5

0.2

K

Ik

̂01

̂02

̂11

̂12

max

min

1000

5

1.060

1.052

1.059

1.052

1.059

1.025

1000

10

1.056

1.058

1.048

1.055

1.111

1.036

1000

5

1.048

1.044

1.048

1.044

1.048

1.011

1000

10

1.033

1.021

1.031

1.021

1.037

1.017

1000

5

1.043

1.036

1.043

1.037

1.043

1.004

1000

10

1.027

1.018

1.026

1.018

1.027

1.009
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Appendix K
This appendix is a web appendix for the Chapter 3 paper submission.

Table K.1. Parameter estimates and estimated standard errors (in parentheses)
for the parsimonious model described in Section 3.5. The GEE column
corresponds to a model fit to the individual responses using GEE methodology.
Term

Disease

ES

GEE

Gonorrhea

-5.76(0.61)

-

Chlamydia

-0.53(0.42)

-

Gonorrhea

-0.03(0.02)

-

Chlamydia

-0.11(0.02)

-

Gonorrhea

1.84(0.34)

1.31(0.17)

Chlamydia

0.58(0.20)

0.40(0.10)

Gonorrhea

0.75(0.98)

0.71(0.34)

Chlamydia

1.06(0.24)

0.69(0.14)

Gonorrhea

0.45(0.93)

-

Chlamydia

0.04(0.40)

0.06(0.15)

Gonorrhea

1.24(0.42)

0.95(0.17)

Chlamydia

0.40(0.17)

0.28(0.08)

Cervical friability

Both

0.27(0.28)

0.10(0.16)

Pelvic inflammatory

Both

0.63(0.55)

0.62(0.34)

Cervicitis

Both

0.50(0.18)

0.58(0.10)

Gonorrhea

1.22(0.30)

1.04(0.17)

Chlamydia

0.27(0.22)

0.47(0.10)

Both

0.11(0.18)

-

Gonorrhea

1.33(0.29)

1.17(0.18)

Chlamydia

0.59(0.21)

0.94(0.10)

Intercept

Age

Race level #1

Race level #2

Race level #3

Symptoms

Multiple partners
New partner
Contact to a STD

